Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Neonatology

  Free Subscription


Articles published in Pediatr Pulmonol

Retrieve available abstracts of 579 articles:
HTML format



Single Articles


    November 2026
  1. FIDANOGLU V, Selcuk Z, Saka S, Cakir E, et al
    Beyond the Lungs: Social and Parental Factors Associated With Exercise Capacity and Respiratory Muscle Strength in Children With Cystic Fibrosis.
    Pediatr Pulmonol. 2026;61:e71898.
    PubMed     Abstract available


  2. OZAN E, Ozturk S, Akcan AB, Erge D, et al
    Subtle Alterations of Tidal Breathing Variables in Healthy Late Preterm Neonates at Term-Equivalent Age.
    Pediatr Pulmonol. 2026;61:e71889.
    PubMed     Abstract available


  3. SANDERS DB, Shah Y, Cordova JMG, Saunders JL, et al
    The Association Between Meconium Ileus and Nutritional and Pulmonary Outcomes in Children With Cystic Fibrosis.
    Pediatr Pulmonol. 2026;61:e71895.
    PubMed     Abstract available


  4. CANAS JA, Serrano-Santiago A, Alonso-Lopez P, Rodriguez-Gonzalez D, et al
    Cytokine Profile Changes in Infants With Respiratory Syncytial Virus Bronchiolitis With Nirsevimab.
    Pediatr Pulmonol. 2026;61:e71900.
    PubMed    


  5. NOONE AN, Goddard T, Crawford TM, Andersen CC, et al
    The Use of Overnight Oximetry and Polysomnography in Late Preterm to Term Newborns Requiring Home Oxygen at Discharge.
    Pediatr Pulmonol. 2026;61:e71906.
    PubMed     Abstract available


    October 2026
  6. CHOUROU H, Ben Aziza R, Belhadj Ammar W, Saadi C, et al
    Congenital Lung Malformations in Neonates: A 9-Year Tunisian Cohort Highlighting Diagnostic Challenges and Outcomes in a Resource-Limited Setting.
    Pediatr Pulmonol. 2026;61:e71846.
    PubMed     Abstract available


  7. VANDEWAL K, Boon M, Weynand B, Vandersnickt J, et al
    When Imaging Misleads: A Hyperlucent Lung Lesion in a Newborn.
    Pediatr Pulmonol. 2026;61:e71844.
    PubMed    


  8. WILDER A, Schindler T, Saikumar P, Patel D, et al
    Nephrolithiasis in Cystic Fibrosis: A Gastrointestinal Perspective on Mechanisms and Management.
    Pediatr Pulmonol. 2026;61:e71848.
    PubMed     Abstract available


  9. LI Z, Wang Q, Liu R, Hu X, et al
    From Selective Prophylaxis to Broad Infant RSV Protection: A Bibliometric Analysis and Evidence Gap Map, 1998-2025.
    Pediatr Pulmonol. 2026;61:e71853.
    PubMed     Abstract available


  10. KORKMAZ C, Akpinar OT, Kilic A, Kartkaya SD, et al
    Residual-Function and Splicing CFTR Variants Characterize False-Negative IRT Newborn Screening: A Ten-Year Single-Center Cohort From Turkiye.
    Pediatr Pulmonol. 2026;61:e71864.
    PubMed     Abstract available


  11. ALI K, Alsenani M, Alshareedah S, Sufyani M, et al
    Temporal Dynamics and Clinical Relevance of Oscillatory Amplitude Variability During High-Frequency Oscillatory Ventilation With Volume Guarantee in Preterm Infants.
    Pediatr Pulmonol. 2026;61:e71859.
    PubMed     Abstract available


  12. BERGMAN-SIEGER A, Turcot MA, Ostrowski LE, Sears PR, et al
    Variants in CEP135 Cause Congenital Microcephaly and Primary Ciliary Dyskinesia.
    Pediatr Pulmonol. 2026;61:e71866.
    PubMed     Abstract available


  13. BOAS H, Bennett L, Faerber J, Donnelly EC, et al
    Assessment of Cystic Fibrosis Lung Disease Using Electrical Impedance Tomography.
    Pediatr Pulmonol. 2026;61:e71856.
    PubMed     Abstract available


  14. HEIDARZADEH F, Pournajaf S, Akbarian-Rad Z, Bozorgnezhad N, et al
    Effectiveness of Surfactant Administration in Two Different Methods (MIST, INSURE) on the Short-Term Outcome of Preterm Infants With Respiratory Distress Syndrome: A Randomized Clinical Trial.
    Pediatr Pulmonol. 2026;61:e71874.
    PubMed     Abstract available


  15. HEIMBRUCH K, Strong S, Wackler M, Taylor M, et al
    Navigating School While Living With Cystic Fibrosis: Barriers and Support Strategies From the Patient and Family Perspective.
    Pediatr Pulmonol. 2026;61:e71870.
    PubMed     Abstract available


  16. BULFAMANTE AM, Pierucci UM, Campari A, Zirpoli S, et al
    Congenital Lung Malformations and Quantitative Assessment of Infant Tracheal-Bronchial Dimensions.
    Pediatr Pulmonol. 2026;61:e71876.
    PubMed     Abstract available


  17. KULKARNI A, Richards J, Fatima T, Chellen S, et al
    Effects of Neurally Adjusted Ventilatory Assist on Lung Ultrasound Aeration and Diaphragmatic Function in Extremely Preterm Infants With Evolving or Established Bronchopulmonary Dysplasia.
    Pediatr Pulmonol. 2026;61:e71885.
    PubMed     Abstract available


    September 2026
  18. PRANEETHA M, Som T, Mohanty P, Sahoo T, et al
    Less Invasive Surfactant Administration Using Video Laryngoscope to Decrease Pain in Neonates: A Randomized Controlled Trial.
    Pediatr Pulmonol. 2026;61:e71808.
    PubMed     Abstract available


  19. SHEPPARD M, Massie J
    Ethical Considerations With CFTR Modulator Use in Pregnancy.
    Pediatr Pulmonol. 2026;61:e71806.
    PubMed     Abstract available


  20. ANGEL JR, Guitterez JL, Weiner DJ, Kurland G, et al
    Diagnosis of Post-Infectious Bronchiolitis Obliterans: Guiding Treatment With Infant Pulmonary Function Testing.
    Pediatr Pulmonol. 2026;61:e71792.
    PubMed    


  21. KUMAR S, Gupta N, Singh SK, Srinivasan H, et al
    Comment on "Asthma in Children With Congenital Lung Malformations: A Population-Based Case-Control Study".
    Pediatr Pulmonol. 2026;61:e71805.
    PubMed    


  22. SOUSA MLA, Balzani E, Dubo S, Coelho AAC, et al
    Association Between Diaphragm Ultrasound Measures and Extubation Outcomes in Neonates: A Systematic Review and Meta-Analysis.
    Pediatr Pulmonol. 2026;61:e71807.
    PubMed     Abstract available


  23. DE ALMEIDA IS, Vendrusculo FM, da Costa MS, Donadio MVF, et al
    CFTR Modulator Therapy and Aerobic Fitness Changes in Aerobic Fitness Following Initiation of CFTR Modulator Therapy: A Systematic Review and Meta-Analysis.
    Pediatr Pulmonol. 2026;61:e71826.
    PubMed     Abstract available


  24. LONABAUGH KP, Jacobs H, Orofino J, Saville L, et al
    Reproductive Futures in Focus: Contraceptive Choices Among Individuals With Cystic Fibrosis-Patterns, Preferences, and Influencing Factors.
    Pediatr Pulmonol. 2026;61:e71809.
    PubMed     Abstract available


  25. ROEKE L, van de Ven LI, Vonk SEM, Coremans JJM, et al
    Real-World Medication Adherence and Medication Reviews in Adults and Children With Cystic Fibrosis.
    Pediatr Pulmonol. 2026;61:e71815.
    PubMed     Abstract available


  26. QUEENER P, Ross EL, Deterding R
    Novel Dosing, Monitoring, and Safety Assessment for Cyclosporine in the Management of ABCA3 Surfactant Dysfunction in an Infant.
    Pediatr Pulmonol. 2026;61:e71825.
    PubMed    


  27. BEULLENS N, Smets K, De Lausnay M, Schelstraete P, et al
    Neonatal Course and Long-Term Outcome in Children With Congenital Chylothorax.
    Pediatr Pulmonol. 2026;61:e71820.
    PubMed     Abstract available


  28. MOORE HL, Stanojevic S, Gibbons JTD, Bates A, et al
    Data Collection and Harmonization in Preterm Respiratory Research: Recommendations and Insights From PELICAN.
    Pediatr Pulmonol. 2026;61:e71812.
    PubMed     Abstract available


  29. RAO Y, Wang X, Li Q, Yang L, et al
    Human Milk and Bronchopulmonary Dysplasia in Preterm Infants: The Mediation of Inflammatory Cytokines.
    Pediatr Pulmonol. 2026;61:e71836.
    PubMed     Abstract available


  30. WRIGHT BA, McKinzie CJ, Kam CW, Tak CR, et al
    The Cost of Control: Financial and Administrative Burdens of Limited Distribution Network Changes in Cystic Fibrosis.
    Pediatr Pulmonol. 2026;61:e71829.
    PubMed     Abstract available


  31. BUENDIA JA, Patino DG
    Population-Based Epidemiology of Congenital Pulmonary Malformations in Early Infancy: A Nationwide Study From Colombia.
    Pediatr Pulmonol. 2026;61:e71841.
    PubMed     Abstract available


  32. BROOKS L, Goudy S, Jergel A, Reeder W, et al
    Respiration and Ventilation Outcomes With Passy Muir Valve Use in Infants and Children Requiring Mechanical Ventilation via Tracheostomy.
    Pediatr Pulmonol. 2026;61:e71834.
    PubMed     Abstract available


    August 2026
  33. SMITH C, Chadwick HK, Peckham DG, Hill K, et al
    Bridging the Gap: Translated Medical Education to Support Cystic Fibrosis Centers From Non-English Speaking Countries.
    Pediatr Pulmonol. 2026;61:e71764.
    PubMed     Abstract available


  34. FAVA J, Stephan E, Tansmore J, Sheikh S, et al
    Impact of Elexacaftor/Tezacaftor/Ivacaftor on Systemic Antibiotic Utilization in Pediatric Patients With Cystic Fibrosis.
    Pediatr Pulmonol. 2026;61:e71749.
    PubMed     Abstract available


  35. BARRY J, van Hasselt JGC, Evans M, Hirsch EB, et al
    Population Pharmacokinetic and Exposure-Response Analysis of Vancomycin Nephrotoxicity in Cystic Fibrosis Patients.
    Pediatr Pulmonol. 2026;61:e71748.
    PubMed     Abstract available


  36. VANVUCHELEN L, Vermaut A, Proesmans M, Vermeulen F, et al
    Comparing Multiple Breath Washout Parameters in a Matched Cohort of Children With Cystic Fibrosis and Primary Ciliary Dyskinesia.
    Pediatr Pulmonol. 2026;61:e71735.
    PubMed     Abstract available


  37. SHINOHARA S, Yasuda G, Kasai M, Katsumata N, et al
    Timing of Magnesium Sulfate Cessation and Apnea of Prematurity in Late-Preterm Twin Infants.
    Pediatr Pulmonol. 2026;61:e71755.
    PubMed     Abstract available


  38. IKEDA K, Hasegawa H, Yamada Y, Wasa M, et al
    Ventilatory Response to CO(2) During Exercise in Patients With Congenital Central Hypoventilation Syndrome.
    Pediatr Pulmonol. 2026;61:e71767.
    PubMed     Abstract available


  39. SHRIDEVI K, Doiphode M, Mishra R, Dhyani A, et al
    Comment on "Early Life Food Desert Status Is Associated With Alpha and Gamma-Tocopherol Levels and Infant Lung Function".
    Pediatr Pulmonol. 2026;61:e71752.
    PubMed    


  40. MAHIDA K, Jagtap SR
    Comment on "Early Life Food Desert Status Is Associated With Alpha and Gamma Tocopherol Levels and Infant Lung Function".
    Pediatr Pulmonol. 2026;61:e71754.
    PubMed    


  41. KAM CW, Bullington W, Elliott A, Faircloth JM, et al
    Management Strategies for Hepatotoxicity Associated With Elexacaftor/Tezacaftor/Ivacaftor: Results of a Provider Survey.
    Pediatr Pulmonol. 2026;61:e71778.
    PubMed     Abstract available


  42. FOUGHT MK, O'Connor JB, Wagner BD, Quinn AC, et al
    Cathepsin B, Airway Pathogens, and Inflammation in the Lower Airways of Children With Cystic Fibrosis.
    Pediatr Pulmonol. 2026;61:e71793.
    PubMed     Abstract available


  43. DAVIS MD, Smith L, Zhao Y, Rahman RA, et al
    Human Nasal and Bronchial Epithelium in Cystic Fibrosis: Differences in Expression of Airway pH Regulatory Proteins.
    Pediatr Pulmonol. 2026;61:e71784.
    PubMed     Abstract available


  44. LOEL F, McMahon T, Matson AG, Kumar S, et al
    Exploring Longterm Gastrostomy Use in Adults With Cystic Fibrosis.
    Pediatr Pulmonol. 2026;61:e71781.
    PubMed     Abstract available


  45. SANKARARAMAN S, Schindler T, Thavamani A, Pamer C, et al
    Utilization of Des-Gamma-Carboxy-Prothrombin in Estimating Vitamin K Status in People With Cystic Fibrosis: A Single Center Retrospective Review.
    Pediatr Pulmonol. 2026;61:e71777.
    PubMed     Abstract available


  46. JURKIEWICZ A, Marczak H, Strzelak A
    Respiratory Physiotherapy for Chest Wall Deformity in an Infant With Neuroendocrine Cell Hyperplasia of Infancy.
    Pediatr Pulmonol. 2026;61:e71789.
    PubMed    


  47. DUNCAN CL, von Isenburg M, Green A, Ford C, et al
    Caregiver Mental Health and Its Relation to Child and Adolescent Mental and Behavioral Health in the Era of Highly Effective Modulator Therapy for Cystic Fibrosis.
    Pediatr Pulmonol. 2026;61:e71794.
    PubMed     Abstract available


  48. HARTIKAINEN A, Kiviranta P, Rasanen K, Kuitunen I, et al
    Overview of the Effectiveness of Different Surfactant Administration Methods: An Umbrella Review of Meta-Analyses.
    Pediatr Pulmonol. 2026;61:e71799.
    PubMed     Abstract available


  49. GUSTAFSON B, Young B
    Complete Tracheal Rings and Congenital Diaphragmatic Hernia: A Case Series.
    Pediatr Pulmonol. 2026;61:e71795.
    PubMed    


    July 2026
  50. ROJAS-MCKENZIE M, Fraga JP, Iturriaga C, Hernandez C, et al
    Early Use of Proton Pump Inhibitors Increases Risk of Upper Respiratory Tract Infections in Children: A Birth Cohort Study.
    Pediatr Pulmonol. 2026;61:e71715.
    PubMed     Abstract available


  51. SUN X, Yarza S, Kuang Y, Sharma S, et al
    Safety of Less Invasive Surfactant Administration in Preterm Infants: A Meta-Analysis.
    Pediatr Pulmonol. 2026;61:e71718.
    PubMed     Abstract available


  52. BUENDIA JA, Vasquez C
    Administrative Prevalence and Healthcare Utilization of Pediatric Cystic Fibrosis in a Middle-Income Country: A 10-Year Analysis of National Administrative Data.
    Pediatr Pulmonol. 2026;61:e71717.
    PubMed     Abstract available


  53. DOSSCHE LWJ, Farjam G, Zuidweg MJP, Iqbal S, et al
    Asthma in Children With Congenital Lung Malformations: A Population-Based Case-Control Study.
    Pediatr Pulmonol. 2026;61:e71714.
    PubMed     Abstract available


  54. MCCOY J, Behrman M, Robichaud J, Bruce AS, et al
    From Awareness to Action: Developing A Cystic Fibrosis-Tailored Screening for Disordered Eating Behaviors.
    Pediatr Pulmonol. 2026;61:e71728.
    PubMed     Abstract available


  55. PARRA-BUITRAGO A, Jaramillo-Cerezo A, Buendia JA
    Uncovering Hidden Phenotypes of Bronchopulmonary Dysplasia: A Latent Class Analysis of Preterm Infants in a Middle-Income Setting.
    Pediatr Pulmonol. 2026;61:e71732.
    PubMed     Abstract available


  56. EFTHYVOULOU C, Semple T, Abkir M, Tibiletti M, et al
    Postural Influence on Ventilation Efficiency and Relationship With Oxygen-Enhanced MRI in Cystic Fibrosis.
    Pediatr Pulmonol. 2026;61:e71724.
    PubMed     Abstract available


  57. MUNDI K, Kieran E, Dyk JV, Wen E, et al
    Home Non-Invasive Ventilation as an Alternative to Tracheostomy in Infants With Moderate-to-Severe Bronchopulmonary Dysplasia: A Retrospective Cohort Study.
    Pediatr Pulmonol. 2026;61:e71726.
    PubMed     Abstract available


  58. DAVIES JC, Bakkeheim E, Chansard A, Drevinek P, et al
    Perspective of the European Cystic Fibrosis Society on Improving Global Cystic Fibrosis Care.
    Pediatr Pulmonol. 2026;61:e71720.
    PubMed     Abstract available


  59. EULLER H, de Andrade AD, Xavier D, Silva T, et al
    Agreement of Diaphragmatic Excursion Between Anterior Subcostal and Posterior Subcostal Ultrasonography in Premature Neonates.
    Pediatr Pulmonol. 2026;61:e71730.
    PubMed     Abstract available


  60. HUNT WR, Merlo C, Keller A, Lowe K, et al
    Meaningful Criteria to Persons Living With Cystic Fibrosis and Their Healthcare Providers in Helping Determine Adjustments to Routine Clinical Follow-Up.
    Pediatr Pulmonol. 2026;61:e71729.
    PubMed     Abstract available


  61. OPHIR Y, Tukova J
    Bronchodilator Responsiveness in Preterm-Born Children With Chronic Lung Disease: Importance of Individualized Testing.
    Pediatr Pulmonol. 2026;61:e71742.
    PubMed     Abstract available


  62. CAPASSO L, Carandente R, Cipullo M, Grasso F, et al
    Electrical Impedance Tomography and Lung Ultrasound, a New Combined Non-Invasive Approach for Neonatal Respiratory Distress: A Case Report.
    Pediatr Pulmonol. 2026;61:e71739.
    PubMed    


  63. OLIVIER L, Lauterbach Oprea C, Stollenwerk A, Pfannschmidt V, et al
    Correlation of Transcutaneous pCO(2) and Capillary pCO(2) in Newborn Patients Depending on Gestational Age: A Secondary Data Analysis.
    Pediatr Pulmonol. 2026;61:e71733.
    PubMed     Abstract available


  64. PATEL D, King J, Wilder A, Al-Hammadi N, et al
    Divergent Management of the Foregut Between Pulmonologists and Gastroenterologists in Advanced Cystic Fibrosis Lung Disease.
    Pediatr Pulmonol. 2026;61:e71740.
    PubMed     Abstract available


  65. SHENOY A, Southern K
    Cystic Fibrosis Newborn Screening: Cost Trajectory as a Marker to Improve Health Outcomes.
    Pediatr Pulmonol. 2026;61:e71747.
    PubMed    


    June 2026
  66. FAMULSKA P, Wieckowska B, Narozna B, Sapiejka E, et al
    Comparison of Long Term Effects of Treatment of Different CFTR Modulators in People With Cystic Fibrosis.
    Pediatr Pulmonol. 2026;61:e71681.
    PubMed     Abstract available


  67. TAN L, Borowiec A, Reed JA, Rath M, et al
    Clinical Use of Home Spirometry in Children With Cystic Fibrosis.
    Pediatr Pulmonol. 2026;61:e71691.
    PubMed     Abstract available


  68. JOURET N, Verhulst S, Van Hoorenbeeck K
    Melatonin to Induce Natural Sleep During Multiple-Breath Washout in Infants and Toddlers With Cystic Fibrosis.
    Pediatr Pulmonol. 2026;61:e71688.
    PubMed     Abstract available


  69. TARIZZO M, Mesinele J, Prevost B, Denamur S, et al
    Impact of RSV Preventive Strategies on Hospitalizations for Bronchiolitis in Infants.
    Pediatr Pulmonol. 2026;61:e71689.
    PubMed     Abstract available


  70. ZUIKI M, Iwata N, Watanabe K, Taniguchi A, et al
    Volumetric Capnography for Assessing Pre- and Post-Operative Intrapulmonary Shunt in Congenital Pulmonary Lymphangiectasia: A Case Report.
    Pediatr Pulmonol. 2026;61:e71699.
    PubMed    


  71. TEPER A, Rodriguez V, Lubovich S, Zaragoza S, et al
    Real-Life Experience With a Generic Formulation of Elexacaftor/Tezacaftor/Ivacaftor in Patients With Cystic Fibrosis With Responding Variants.
    Pediatr Pulmonol. 2026;61:e71706.
    PubMed     Abstract available


  72. RAMIREZ VO, Wambach JA, Nevel RJ, Voss L, et al
    Respiratory Outcomes in Children With Neonatal Respiratory Distress Syndrome and Monoallelic ABCA3 Variants.
    Pediatr Pulmonol. 2026;61:e71695.
    PubMed     Abstract available


  73. KAUR J, Hedlund A, Dollimount A, Lockinger K, et al
    A Qualitative Study of the Lived Experiences and Needs of Parent Caregivers of People With Cystic Fibrosis.
    Pediatr Pulmonol. 2026;61:e71703.
    PubMed     Abstract available


  74. BHATNAGAR R, Bhardwaj N, Masukume G, Segurado R, et al
    Performance Evaluation of a Novel Cystic Fibrosis Caregiver Burden Measure Demonstrates Significant Challenges for Parents of Children With CF During the Early Years: The Irish Comparative Outcomes Study (ICOS).
    Pediatr Pulmonol. 2026;61:e71694.
    PubMed     Abstract available


  75. AERSSENS N, Vermeulen F, Boon M, Proesmans M, et al
    Real-World Clinical Outcomes of Lumacaftor-Ivacaftor or Tezacaftor-Ivacaftor Therapy in Children With Cystic Fibrosis Homozygous for Phe508del.
    Pediatr Pulmonol. 2026;61:e71701.
    PubMed     Abstract available


  76. MIRALDA I, Aridgides DS, Ozuna H, Britt RD Jr, et al
    Cystic Fibrosis-Asthma Overlap Syndrome: Current Understanding and Future Directions.
    Pediatr Pulmonol. 2026;61:e71682.
    PubMed     Abstract available


  77. PARRA-BUITRAGO A, Jaramillo-Cerezo A, Cuellar-Santaella M, Giraldo Ospina GA, et al
    The Hidden Variant: Intronic ABCA3 Mutation in Lethal Neonatal Interstitial Lung Disease.
    Pediatr Pulmonol. 2026;61:e71692.
    PubMed    


  78. GUASTI E, Tardini G, Buratti S, Campone C, et al
    Alveolar Capillary Dysplasia With Misaligned Pulmonary Veins (ACDMPV): Description of Two Cases and Literature Review.
    Pediatr Pulmonol. 2026;61:e71704.
    PubMed     Abstract available


  79. BUITRAGO AP, Acuna-Cordero R, Buendia JA
    Bronchopulmonary Dysplasia in Early Infancy: A Nationwide Population-Based Study of Prevalence and Care Utilization in Colombia.
    Pediatr Pulmonol. 2026;61:e71713.
    PubMed     Abstract available


  80. BULFAMANTE AM, Pierucci UM, Imbrogno G, Leon LAO, et al
    Congenital Pulmonary Airway Malformations in Children: Beyond the Pulmonary Cystic Lesion Is There Really an Associated Laryngo-Tracheal Abnormality?
    Pediatr Pulmonol. 2026;61:e71687.
    PubMed     Abstract available


  81. AOYAMA BC, McGrath-Morrow SA, Collaco JM
    The Use of Outpatient Diuretics Does Not Impact Somatic Growth in Infants With Bronchopulmonary Dysplasia.
    Pediatr Pulmonol. 2026;61:e71712.
    PubMed    


    May 2026
  82. RIVERA-FIGUEROA KL, Martin CL, Le CA, Rojas WJ, et al
    Challenges to Assessing the Prevalence of Cystic Fibrosis in the Caribbean.
    Pediatr Pulmonol. 2026;61:e71648.
    PubMed     Abstract available


  83. SANKARARAMAN S, Hendrix S, Neudecker M, Borowitz D, et al
    Utility of Fecal Elastase-1 in Estimating Exocrine Pancreatic Function in Cystic Fibrosis: A Scoping Review.
    Pediatr Pulmonol. 2026;61:e71649.
    PubMed     Abstract available


  84. BROWN S, Williams D, Duckers J, Kazmerski TM, et al
    Considerations for the Role and Implementation of Reproductive Health Shared Decision-Making Interventions for Cystic Fibrosis: A Qualitative Investigation of Perspectives From Clinicians and Females With Cystic Fibrosis.
    Pediatr Pulmonol. 2026;61:e71643.
    PubMed     Abstract available


  85. LANGFELDER-SCHWIND E, Kay DM, Berdella M, DeCelie-Germana JK, et al
    Evolution of the New York State Cystic Fibrosis Newborn Screening Algorithm: Two Decades of Experience.
    Pediatr Pulmonol. 2026;61:e71650.
    PubMed    


  86. STRAUCH L, Lang P 2nd, Cheema Z, Winter C, et al
    Urine Metabolomics to Predict Bronchopulmonary Dysplasia: A Single-Center Prospective Study.
    Pediatr Pulmonol. 2026;61:e71644.
    PubMed     Abstract available


  87. FLORA C, Engdahl S, Pettit RS
    Tobramycin Pharmacokinetics in Pediatric People With Cystic Fibrosis on Maintenance Azithromycin.
    Pediatr Pulmonol. 2026;61:e71666.
    PubMed     Abstract available


  88. FUCHS T, Donovan J, Ives A, Irving S, et al
    Function and Structure Relationships With Inflammation Differ in Two Chronic Suppurative Lung Diseases.
    Pediatr Pulmonol. 2026;61:e71659.
    PubMed     Abstract available


  89. KUMAR M, Gatt D, Zysman-Colman Z, Fontoura-Matias J, et al
    Early Life Disease Burden and Outcomes in Children Diagnosed With Primary Ciliary Dyskinesia in Infancy.
    Pediatr Pulmonol. 2026;61:e71658.
    PubMed     Abstract available


  90. WANG C, Feng Z, Wang S, Feng X, et al
    Therapeutic Adjustment According to Bedside Ventilation-Perfusion Measurement in Postoperative Infant With Complex Congenital Heart Disease.
    Pediatr Pulmonol. 2026;61:e71660.
    PubMed    


  91. HUNG YL, Hsieh WS
    Comment on "Umbilical Artery Leucine-Rich alpha-2 Glycoprotein as a Predictor of Bronchopulmonary Dysplasia in Preterm Infants".
    Pediatr Pulmonol. 2026;61:e71657.
    PubMed    


  92. NENEMAN J, Wiesner A, Szpecht D, Wojsyk-Banaszak I, et al
    Lung Ultrasound and Lung Clearance Index After Preterm Birth: A Structure-Function Framework for Bronchopulmonary Dysplasia and Post-Prematurity Respiratory Disease.
    Pediatr Pulmonol. 2026;61:e71671.
    PubMed     Abstract available


  93. ULUER A, Ratner L, Asfour F, Elshaar N, et al
    Cystic Fibrosis Transition From Pediatrics to Adult Care in Low-Middle Income Countries.
    Pediatr Pulmonol. 2026;61:e71645.
    PubMed     Abstract available


  94. VITALE RJ, Ford C, Filigno SS, Sweeney L, et al
    The Impact of Cystic Fibrosis-Related Diabetes on Barriers to Self-Management.
    Pediatr Pulmonol. 2026;61:e71661.
    PubMed     Abstract available


  95. KARZOUN D, Hojsgaard A, Petersen OB, Bindzus S, et al
    Congenital Pulmonary Malformation-Management and Long-Term Outcomes of a Danish Cohort.
    Pediatr Pulmonol. 2026;61:e71676.
    PubMed     Abstract available


  96. LA REGINA DP, Spatuzzo M, Bonci E, Nenna R, et al
    Virus Detection and Hospitalization Rate in Infants With Bronchiolitis After Nirsevimab Introduction: A Retrospective Comparative Two-Season Study.
    Pediatr Pulmonol. 2026;61:e71647.
    PubMed     Abstract available


  97. CHANDORKAR N, Kumar G, Singh G, Siddiqui K, et al
    Early Versus Conventional Discontinuation of Caffeine Therapy for Apnea of Prematurity: A Randomized Controlled Trial-The DECaf Trial.
    Pediatr Pulmonol. 2026;61:e71677.
    PubMed     Abstract available


    April 2026
  98. KARABULUT S, Kalyoncu MY, Balci MS, Cakar NM, et al
    Transforming Care in Cystic Fibrosis: The Long-Term Impact of Quality Improvement Projects on Clinical Outcomes.
    Pediatr Pulmonol. 2026;61:e71597.
    PubMed     Abstract available


  99. KIMBER F, Sills D
    The Impact of Elexacaftor/Tezacaftor/Ivacaftor on Fat-Soluble Vitamin Status and Supplementation in a Pediatric Cystic Fibrosis Cohort.
    Pediatr Pulmonol. 2026;61:e71596.
    PubMed     Abstract available


  100. GALLARDO R, Silva BS, Salgado LS, Ribeiro JD, et al
    Systematic Review of Nasal Endoscopy Scores in Cystic Fibrosis Patients Treated With Cystic Fibrosis Transmembrane Conductance Regulator Modulators.
    Pediatr Pulmonol. 2026;61:e71601.
    PubMed     Abstract available


  101. FOUGHT MK, Hong G, Quinn AC, Wagner BD, et al
    Molecular Methods to Detect and Quantify Fungal Communities in Cystic Fibrosis Airway Specimens.
    Pediatr Pulmonol. 2026;61:e71598.
    PubMed     Abstract available


  102. SUN Y, Du J, Gong L, Wang J, et al
    Current Status and the Need for CFTR Modulator Therapy in Cystic Fibrosis Patients in Mainland China: A Case Report and Literature Review.
    Pediatr Pulmonol. 2026;61:e71590.
    PubMed     Abstract available


  103. WALSH A, Donadio MVF, D'Agostino G, Wood H, et al
    Supporting Physiotherapy and Exercise for People With Cystic Fibrosis in Low-Resource Settings.
    Pediatr Pulmonol. 2026;61:e71459.
    PubMed     Abstract available


  104. LOVEYS K, Borland ML, Oakley E, Babl FE, et al
    Investigations for Bronchiolitis in Infants: An Overview of Reviews and Systematic Review of Primary Studies.
    Pediatr Pulmonol. 2026;61:e71582.
    PubMed     Abstract available


  105. HEVRONI A, Wetzler NJ, Gileles-Hillel A, Cohen-Cymberknoh M, et al
    The Impact of Small-for-Gestational-Age on Pulmonary Function in Infancy, a Retrospective Cohort Study.
    Pediatr Pulmonol. 2026;61:e71599.
    PubMed     Abstract available


  106. PERKINS RC, Davis J, Alao M, Allen S, et al
    Money Talks (But Do We?): Evaluating Perceptions and Practices of Financial Conversations by Cystic Fibrosis Clinicians.
    Pediatr Pulmonol. 2026;61:e71612.
    PubMed     Abstract available


  107. PRANSKE M, Paracha A, Loncarich C, Hendrix-Dicken AD, et al
    Improving Pancreatic Function With Elexacaftor/Tezacaftor/Ivacaftor.
    Pediatr Pulmonol. 2026;61:e71616.
    PubMed     Abstract available


  108. HINTON AC, Sears EH Jr, Lopez-Pintado S, Zuckerman JB, et al
    Impact of COVID-19 and CFTR Modulators on Cystic Fibrosis: A Real-World Analysis of Care Patterns.
    Pediatr Pulmonol. 2026;61:e71595.
    PubMed     Abstract available


  109. KROES S, Taylor-Cousar JL, Zampoli M, Karadag B, et al
    Patient-Derived Intestinal Organoids in the Global Cystic Fibrosis Landscape.
    Pediatr Pulmonol. 2026;61:e71584.
    PubMed     Abstract available


  110. KEKEC H, Eyuboglu TS, Aslan AT, Medeni V, et al
    The Evaluation of the Genotype and Phenotype Relationship in Patients With Nasal Polyps in Cystic Fibrosis Registry of Turkey.
    Pediatr Pulmonol. 2026;61:e71608.
    PubMed     Abstract available


  111. FROTA SCM, Macedo LES, Oliveira LQ, Bezerra IFD, et al
    Premature Infants With Pulmonary Complications Exhibit Decreased Skin Maturity Early After Birth: A Cross-Sectional Study.
    Pediatr Pulmonol. 2026;61:e71562.
    PubMed     Abstract available


  112. HUSSEIN MM, Nasr SZ, Kamel TB, Rashad M, et al
    Impact of a Standardized Multidisciplinary Quality Improvement Project to Improve Clinical Outcomes in Cystic Fibrosis: A 12-Month Phased Project at Ain Shams University.
    Pediatr Pulmonol. 2026;61:e71621.
    PubMed     Abstract available


  113. TRACY MC, Collaco JM, Akangire G, Bamat NA, et al
    Outpatient Medication Prescribing Patterns in Bronchopulmonary Dysplasia: A Survey of Clinical Practices and Challenges.
    Pediatr Pulmonol. 2026;61:e71622.
    PubMed     Abstract available


  114. TRAVERS CP, Carlo WA, Kulkarni YK, Armstead KM, et al
    Measuring the Effects of Furosemide on Lung Mechanics Using Oscillometry in Preterm Infants.
    Pediatr Pulmonol. 2026;61:e71627.
    PubMed    


  115. VANDEMORE DR, Lonergan EK, Rand CM, Weese-Mayer DE, et al
    International Congenital Central Hypoventilation Syndrome (CCHS) Registry: Analysis of Patient-Reported Symptoms by PHOX2B Variant.
    Pediatr Pulmonol. 2026;61:e71619.
    PubMed     Abstract available


  116. MARANGU-BOORE D, Kinuthia D, Maranga J, Ngwatu P, et al
    Pseudo-Bartter Syndrome in a Pancreatic Insufficient Infant With CFTR, DNAH9, LYST and G6PD Variants.
    Pediatr Pulmonol. 2026;61:e71623.
    PubMed    


  117. FARHAN AHMAD K, Minhas H, Arshad R
    Home Microbiological Sampling in a Pediatric Cystic Fibrosis Population: Pandemic Implementation and Ongoing Use.
    Pediatr Pulmonol. 2026;61:e71618.
    PubMed     Abstract available


  118. NASR SZ, Flask CA, Kretzler ME, Slaven JE, et al
    Lung T1-MRI and Multi-Breath Washout Detect Longitudinal Changes in Children 6-11 Years Old After Beginning Elexacaftor/Tezacaftor/Ivacaftor (ETI) Therapy.
    Pediatr Pulmonol. 2026;61:e71628.
    PubMed     Abstract available


  119. CARDENES CML, Santamaria SV, Romero RG, Gonzalez AT, et al
    Exocrine Pancreatic Function in Pediatric Patients After Two Years of Triple CFTR Modulator Therapy: Is It Possible to Restore Pancreatic Function?
    Pediatr Pulmonol. 2026;61:e71625.
    PubMed     Abstract available


  120. ABDULGHANI DW, Gutsche E, Daniel SJ, Sant'Anna G, et al
    Noninvasive Neurally Adjusted Ventilatory Assist for the Management of Severe Tracheobronchomalacia in a Preterm Infant With Bronchopulmonary Dysplasia: A Case Report.
    Pediatr Pulmonol. 2026;61:e71640.
    PubMed    


    March 2026
  121. COOK J, Muntean A, Patel SB, Haque S, et al
    Type 1 Congenital Pulmonary Airway Malformation: Diagnostic Accuracy of Radiological Features.
    Pediatr Pulmonol. 2026;61:e71535.
    PubMed     Abstract available


  122. CELEN YOLDAS T, Sismanlar Eyuboglu T, Ugras Dikmen A, Aslan AT, et al
    Parental Experiences and Coping Strategies of Families Caring for a Child With Cystic Fibrosis.
    Pediatr Pulmonol. 2026;61:e71534.
    PubMed     Abstract available


  123. PAUL GR, Varkki SD, Kabra SK
    Challenges and Practical Solutions in the Management of Cystic Fibrosis in Resource-Limited Countries: The Indian Experience.
    Pediatr Pulmonol. 2026;61:e71530.
    PubMed     Abstract available


  124. CAPRAZ YAVUZ B, Dogru D, Sunman B, Alboga D, et al
    Hypochloremic Hypokalemic Metabolic Alkalosis as a Manifestation of CFTR-Related Disorder.
    Pediatr Pulmonol. 2026;61:e71555.
    PubMed     Abstract available


  125. SOUZA EL, Bomfim VHV, Monte LFV, Mota LR, et al
    CFTR Modulators in Brazil: Not for Everyone-A Comparison of Ineligibility Across Different Regions.
    Pediatr Pulmonol. 2026;61:e71557.
    PubMed     Abstract available


  126. QUITTNER AL, Graziano S, Mohan MP, Smith BA, et al
    Advancing Mental Healthcare for Individuals With Cystic Fibrosis in Low- and Middle-Income Countries.
    Pediatr Pulmonol. 2026;61:e71549.
    PubMed     Abstract available


  127. KARADAG B
    Disparities in Access to Cystic Fibrosis Therapy Across Countries.
    Pediatr Pulmonol. 2026;61:e71560.
    PubMed     Abstract available


  128. BAILEY J, Rose NR, Chalamalla AR, Anderson JD, et al
    Assessing Dietary Patterns and Composition Among Adults With Cystic Fibrosis Taking Highly Effective Modulator Therapy.
    Pediatr Pulmonol. 2026;61:e71532.
    PubMed     Abstract available


  129. ERYILMAZ POLAT S, Yildirim C, Yetisgin H, Aktemur Unlu A, et al
    MLPA-Detected CFTR Exon Deletions in Children With Inconclusive CFTR Sequencing: A Single-Center Experience From Turkiye.
    Pediatr Pulmonol. 2026;61:e71556.
    PubMed     Abstract available


  130. ASFUROGLU P, Asfuroglu A
    Urinary System Involvement in Children With Cystic Fibrosis: A Single-Center Retrospective Cohort.
    Pediatr Pulmonol. 2026;61:e71551.
    PubMed     Abstract available


  131. KELCHTERMANS J
    A Narrative Review of Gene-Environment Interactions in Pediatric Pulmonology.
    Pediatr Pulmonol. 2026;61:e71550.
    PubMed     Abstract available


  132. SISMANLAR EYUBOGLU T, Aslan AT, Hocoglu ZI, Asfuroglu P, et al
    "No Words for Feelings": Alexithymia in Children With Cystic Fibrosis and Their Caregivers.
    Pediatr Pulmonol. 2026;61:e71531.
    PubMed     Abstract available


  133. CHRISTIAN ND, Aoyama BC, McGrath-Morrow SA, Collaco JM, et al
    Respiratory Outcomes in Infants and Children With Bronchopulmonary Dysplasia Living in Rural Areas.
    Pediatr Pulmonol. 2026;61:e71583.
    PubMed     Abstract available


  134. CHENG SY, Zampoli M, Elbert A, Bakkeheim E, et al
    Global Collaboration in Cystic Fibrosis: Lessons From the COVID-19 Pandemic for Low- and Middle-Income Countries.
    Pediatr Pulmonol. 2026;61:e71567.
    PubMed     Abstract available


  135. KALYONCU MY, Gokdemir Y
    Advancements in Sweat Testing Techniques for Cystic Fibrosis: From Classical to Novel Methods.
    Pediatr Pulmonol. 2026;61:e71573.
    PubMed     Abstract available


  136. EYRAUD C, Cassibba J, Hullo E, Coffre A, et al
    A De Novo Variant in NALCN Associated With Arthrogryposis and Neonatal Respiratory Failure: A Case Report.
    Pediatr Pulmonol. 2026;61:e71581.
    PubMed    


  137. IYIGUN F, Isleyen F, Tosun MD, Kavurt AS, et al
    Evaluation of Patients With Pulmonary Hemorrhage in a Tertiary Neonatal Intensive Care Unit in Turkiye.
    Pediatr Pulmonol. 2026;61:e71568.
    PubMed     Abstract available


  138. JENKINSON A, Zivanovic S, Harris C, Dassios T, et al
    Antenatal Maternal Smoking and Lung Function in Very Prematurely Born Children.
    Pediatr Pulmonol. 2026;61:e71572.
    PubMed     Abstract available


  139. AMORES EF, Castillo HA, Osorio GS, Martinez J, et al
    Gestational and Congenital Tuberculosis Case Report: A Dual Fatal Vertical Transmission.
    Pediatr Pulmonol. 2026;61:e71564.
    PubMed    


  140. ELSHAAR S, Zahraldin K, Adel A, Babiker AI, et al
    Mode of Delivery and Neonatal Characteristics as Risk Factors for Childhood Asthma in Qatar: A Case-Control Study.
    Pediatr Pulmonol. 2026;61:e71569.
    PubMed     Abstract available


    February 2026
  141. SHINOHARA S, Yasuda G, Kasai M, Katsumata N, et al
    Preeclampsia and Risk of Apnea of Prematurity in Late Preterm Infants: A Retrospective Cohort Study.
    Pediatr Pulmonol. 2026;61:e71485.
    PubMed     Abstract available


  142. WOLFF GS, Tsoggerel A, Hoji A, Ross SE, et al
    Early Life Food Desert Status Is Associated With Alpha and Gamma-Tocopherol Levels and Infant Lung Function.
    Pediatr Pulmonol. 2026;61:e71479.
    PubMed     Abstract available


  143. MAINZ JG, Greiner V, Sadrieh P, Polte L, et al
    Relating Improvement in Gastrointestinal (CFAbd-Score((c))) and Sinonasal (SNOT) Symptoms During Therapy With Elexacaftor/Tezacaftor/Ivacaftor in CF Patients.
    Pediatr Pulmonol. 2026;61:e71507.
    PubMed     Abstract available


  144. BALCI MS, Gokdemir Y, Eralp EE, Ersu R, et al
    Sleep-Disordered Breathing in Cystic Fibrosis in Low- and Middle-Income Countries.
    Pediatr Pulmonol. 2026;61:e71515.
    PubMed     Abstract available


  145. KAKKOURA MG, Anagnostopoulou P, Kouis P, Michanikou A, et al
    The CARMUCI Study Design: A Double-Blind, Cross-Over Sham-Controlled Trial of Indoor Air Purification in People With Cystic Fibrosis and Primary Ciliary Dyskinesia.
    Pediatr Pulmonol. 2026;61:e71514.
    PubMed     Abstract available


  146. WHITMAN EM, Hauptman M, Hayden LP, Levin JC, et al
    Neighborhood Opportunity and Early Life Indicators of Respiratory Health in Children Born Very Preterm.
    Pediatr Pulmonol. 2026;61:e71501.
    PubMed     Abstract available


  147. KOUROUKLI E, Sarafidis K, Tsanakas J, Hatziagorou E, et al
    Exercise Capacity and Ventilatory Response in Children Who Were Born Preterm, With and Without Bronchopulmonary Dysplasia.
    Pediatr Pulmonol. 2026;61:e71492.
    PubMed     Abstract available


  148. NIRANJAN SJ, Woods BM, Coleman E, Geurs R, et al
    "It Was All Tailored Around Me": Qualitative Evaluation of Clinical Effort Against Smoke Exposure in Cystic Fibrosis (CEASE-CF).
    Pediatr Pulmonol. 2026;61:e71496.
    PubMed     Abstract available


  149. GUNATILAKA CC, Alisher S, Waters M, Xiao Q, et al
    Impact of Surgical Diaphragmatic Repair on Central Airway Shape in Neonatal Congenital Diaphragmatic Hernia.
    Pediatr Pulmonol. 2026;61:e71493.
    PubMed     Abstract available


  150. G T, H M VS, M A G E B, H M J, et al
    Linear Growth in Children With Cystic Fibrosis in the Netherlands Born Between 1997-2004; Results of a Multicenter Cohort Analysis.
    Pediatr Pulmonol. 2026;61:e71504.
    PubMed     Abstract available


  151. ABI-AAD SJ, Tsalatsanis A, Narkewicz M, Leung DH, et al
    The Impact of Elexacaftor-Tezacaftor-Ivacaftor on Biochemical Surrogates of Cystic Fibrosis Hepatobiliary Involvement: A Retrospective Cohort Study.
    Pediatr Pulmonol. 2026;61:e71522.
    PubMed     Abstract available


  152. KILIC KM, Ozkan I, Taylan S
    Global Research Status and Trends in Quality of Life in Children With Cystic Fibrosis From 1985 to 2025: A 40-Year Bibliometric Analysis.
    Pediatr Pulmonol. 2026;61:e71524.
    PubMed     Abstract available


  153. DAGAN A, Hadhud M, Efrati O, Cahanovitc SS, et al
    Real-World Impact of Elexacaftor/Tezacaftor/Ivacaftor in Israeli Children Aged 2-6 With Cystic Fibrosis.
    Pediatr Pulmonol. 2026;61:e71523.
    PubMed     Abstract available


  154. TSANG KD, Caudri D, Zaat C, Tramper-Stranders GA, et al
    Peri and Neonatal Risk Factors and Structural Lung Abnormalities Predict Hypoxic Challenge Test Failure in Infants With Severe Bronchopulmonary Dysplasia.
    Pediatr Pulmonol. 2026;61:e71517.
    PubMed     Abstract available


  155. OLGUN EG, Mertese SC, Demir AM, Bayav S, et al
    Thoracic Duct Embolization in a Case of Congenital Chylothorax.
    Pediatr Pulmonol. 2026;61:e71516.
    PubMed    


  156. KOGIAS C, Sopiadou A, Fouzas S, Vantsi P, et al
    Respiratory Oscillometry and Multimodal Lung Function Assessment of Elexacaftor/Tezacaftor/Ivacaftor Response in Children and Young Adults With Cystic Fibrosis.
    Pediatr Pulmonol. 2026;61:e71527.
    PubMed     Abstract available


  157. GRIMSGAARD I, Henriksen EH, Nielsen BU, Faurholt-Jepsen D, et al
    Management of Cystic Fibrosis-Related Diabetes in Denmark-A Population-Based, Cross-Sectional Study.
    Pediatr Pulmonol. 2026;61:e71533.
    PubMed     Abstract available


    January 2026
  158. BOSETTI A, Micic S, Hector A, Bieli C, et al
    Interrater Reliability of a Modified Bronchoscopy Scoring Tool in Children With Cystic Fibrosis.
    Pediatr Pulmonol. 2026;61:e71452.
    PubMed     Abstract available


  159. KADOUH NK, Nasr SZ, Filbrun A, Phan H, et al
    A Tale of Two Infants: Off-Label Use of Elexacaftor/Tezacaftor/Ivacaftor in Early Cystic Fibrosis Treatment.
    Pediatr Pulmonol. 2026;61:e71444.
    PubMed     Abstract available


  160. PLANTE V, Tabone L, Beck J, Sinderby C, et al
    A physiologic Comparison of Continuous Neurally Adjusted Ventilation (NeuroPAP) Versus Neurally-Adjusted Ventilatory Assist (NAVA) in Infants With Respiratory Failure.
    Pediatr Pulmonol. 2026;61:e71434.
    PubMed     Abstract available


  161. NAEHRLICH L
    Expanding Cystic Fibrosis Registries to the Rest of the World.
    Pediatr Pulmonol. 2026;61:e71445.
    PubMed     Abstract available


  162. KUMMERLI S, Elviro CF, Regamey N, Mornand A, et al
    Impact of Elexacaftor-Tezacaftor-Ivacaftor on Quality of Life in Children With Cystic Fibrosis.
    Pediatr Pulmonol. 2026;61:e71461.
    PubMed     Abstract available


  163. NIU H, McCallum GB, Chang AB, Khan K, et al
    Clinical Profile Identification of Indigenous Infants With Bronchiolitis Through Using Unsupervised Feature Extraction and Clustering.
    Pediatr Pulmonol. 2026;61:e71449.
    PubMed     Abstract available


  164. CELIK E, Uysal P
    The Persistent Respiratory Impact of Respiratory Syncytial Virus (RSV) Bronchiolitis in Infants.
    Pediatr Pulmonol. 2026;61:e71456.
    PubMed     Abstract available


  165. SZETO JJ, Boom K, Radack JK, DeMauro SB, et al
    Associations of Community Material Neighborhood Deprivation With the Diagnosis of Asthma Among Infants With Bronchopulmonary Dysplasia (BPD).
    Pediatr Pulmonol. 2026;61:e71462.
    PubMed     Abstract available


  166. TSOI SM, Parker C, Colglazier E, Cheung S, et al
    The Use of Treprostinil for Bronchopulmonary Dysplasia Associated Pulmonary Hypertension.
    Pediatr Pulmonol. 2026;61:e71448.
    PubMed     Abstract available


  167. GEORGIOPOULOS AM, Smith BA, Aliaj E, Riva D, et al
    Stakeholder Priorities for Cystic Fibrosis Mental Health Research: A Community and Provider Survey.
    Pediatr Pulmonol. 2026;61:e71472.
    PubMed     Abstract available


  168. ZAVERI AK, Yoho B, Blasiole B, Forno E, et al
    Impact of Anesthesia Strategy on Infant Pulmonary Function Test Quality and Duration.
    Pediatr Pulmonol. 2026;61:e71477.
    PubMed     Abstract available


  169. TAYLOR E, Soilemezi D, Urquhart DS, Cunningham S, et al
    Exploring Exercise as Airway Clearance in Cystic Fibrosis: A Qualitative Study From the ExACT-CF Feasibility Trial.
    Pediatr Pulmonol. 2026;61:e71470.
    PubMed     Abstract available


    December 2025
  170. KILANI M, AboShindi H, Al-Iede M, AlZoubi M, et al
    Establishment and Analysis of the First Electronic Cystic Fibrosis Registry in Jordan: Demographic and Clinical Insights.
    Pediatr Pulmonol. 2025;60:e71393.
    PubMed     Abstract available


  171. TAKAMI S, Yokokawa H, Sunouchi T, Yoshida R, et al
    Congenital Lobar Emphysema in the Right Upper Lobe Segment (S1 + 2) That Was Associated With Separate Branching of Right Upper Bronchus (B1 + 2, B3).
    Pediatr Pulmonol. 2025;60:e71407.
    PubMed    


  172. MCKINNEY RL, Popova AP, Guaman MC, Kielt MJ, et al
    Common Severity-Based Definitions of Bronchopulmonary Dysplasia Are not Associated With Outpatient Morbidities.
    Pediatr Pulmonol. 2025;60:e71415.
    PubMed     Abstract available


  173. LYONS ER, Vigers T, Simoni M, Lynn C, et al
    Body Image Perceptions and Elexacaftor/Tezacaftor/Ivacaftor (ETI) Use in Adolescents and Young Adults Living With Cystic Fibrosis.
    Pediatr Pulmonol. 2025;60:e71418.
    PubMed     Abstract available


  174. SUZUKI T, Ueda K, Taniguchi A, Maeda T, et al
    Flow-Driver-Generated Synchronized Nasal Intermittent Positive-Pressure Ventilation Versus Biphasic Positive Airway Pressure After Extubation in Preterm Infants.
    Pediatr Pulmonol. 2025;60:e71410.
    PubMed     Abstract available


  175. YAMAMICHI T, Ibuka S, Yamashita S, Takahashi K, et al
    Surgical Drainage of Tension Pneumomediastinum in a Newborn: A Rare Lifesaving Intervention.
    Pediatr Pulmonol. 2025;60:e71411.
    PubMed    


  176. SOTODATE G, Serada S, Takahashi F, Matsumoto A, et al
    Umbilical Artery Leucine-Rich alpha-2 Glycoprotein as a Predictor of Bronchopulmonary Dysplasia in Preterm Infants.
    Pediatr Pulmonol. 2025;60:e71425.
    PubMed     Abstract available


  177. CORCORAN A, Bennett L, Faerber JA, Ren CL, et al
    Risk Factors and Outcomes of Pulmonary Exacerbations in Infants and Young Children With Cystic Fibrosis.
    Pediatr Pulmonol. 2025;60:e71423.
    PubMed     Abstract available


  178. MCKINNEY RL, Collaco JM, Agarwal A, Baker CD, et al
    Increased Mean Airway Pressure Is Associated With Successful Transition to a Portable Home Ventilator in Patients With Grade 3 Bronchopulmonary Dysplasia.
    Pediatr Pulmonol. 2025;60:e70403.
    PubMed     Abstract available


  179. BEERMANN LC, Demski LS, Eitner L, Dillenhofer S, et al
    Taste and Smell Disorders in Children and Young Adults With Cystic Fibrosis and Primary Ciliary Dyskinesia-A Prospective Comparative Study.
    Pediatr Pulmonol. 2025;60:e71419.
    PubMed     Abstract available


  180. GOMEZ LF, Szeto JJ, Radack JK, Novick-Goldstein NP, et al
    Associations of Early Life Ambient PM(2.5) Exposure With Asthma Risk in a Cohort of Preterm Infants With Bronchopulmonary Dysplasia.
    Pediatr Pulmonol. 2025;60:e71432.
    PubMed     Abstract available


  181. KANTZAVELOU A, Chatzigiannis N, Baltogianni M, Atzemoglou N, et al
    Successful Use of Levosimendan in Four Critically Ill Neonates With Pulmonary Hypertension: A Case Series.
    Pediatr Pulmonol. 2025;60:e71430.
    PubMed    


  182. LANGFELDER-SCHWIND E, Basile M, Moyal-Smith R, Polo J, et al
    Increasing Access to Genetic Counselors With Disease-Specific Expertise: Development of a Centralized Cystic Fibrosis Genetic Counseling Telehealth Model.
    Pediatr Pulmonol. 2025;60:e71416.
    PubMed     Abstract available


  183. WILLIAMS CL, Ansar M, Zhou JJ, Ceppe A, et al
    Provider Knowledge of 2013 Cystic Fibrosis Infection Prevention and Control Guidelines for Outpatient Care.
    Pediatr Pulmonol. 2025;60:e71439.
    PubMed     Abstract available


  184. ALBANOWSKI ML, Prangley A, Stransky OM, Chang JC, et al
    Exploration of MyVoice: CF as a Reproductive Health Decision Support Tool for Adolescent Females With Cystic Fibrosis.
    Pediatr Pulmonol. 2025;60:e71438.
    PubMed     Abstract available


  185. KANAI R, Nagao M, Sato Y, Atsuta J, et al
    Early-Onset Wheeze Trajectories in Infants: The Phenotyping of Wheezing Infants (P-WIN) Study.
    Pediatr Pulmonol. 2025;60:e71437.
    PubMed     Abstract available


    November 2025
  186. ADAIKALAM SA, Rose RS, Sammour IA, Bauer SE, et al
    Using Positive End-Expiratory Pressure to Predict and Quantify Tracheobronchomalacia in Grade 3 Bronchopulmonary Dysplasia.
    Pediatr Pulmonol. 2025;60:e71384.
    PubMed     Abstract available


  187. STAUDE B, Mair EM, Zernickel M, Westhoff A, et al
    Adding Early Postnatal Parameters of Ventilation to Prognostic Models for Pulmonary Outcome in Very Preterm Infants.
    Pediatr Pulmonol. 2025;60:e71335.
    PubMed     Abstract available


  188. GRAZIANO S, Landau EC, Mitmansgrubert H, Verkleij M, et al
    Multidimensional Impacts of Elexacaftor/Tezacaftor/Ivacaftor: Comparisons of Physical and Mental Health Providers' Observations in Cystic Fibrosis in Europe and the United States.
    Pediatr Pulmonol. 2025;60:e71367.
    PubMed     Abstract available


  189. SHEN L, Zou X, Li H, Ai Q, et al
    NHFOV Versus CPAP and NIPPV for Post-Extubation Support in Severe Meconium Aspiration Syndrome.
    Pediatr Pulmonol. 2025;60:e71388.
    PubMed     Abstract available


  190. COLLACO JM, Stephenson N, Aoyama BC, Rice JL, et al
    Impact of Environmental Pollutant Exposures on Bronchopulmonary Dysplasia.
    Pediatr Pulmonol. 2025;60:e71377.
    PubMed     Abstract available


  191. SWANSTON V, Bone JN, Richmond M, Goldfarb D, et al
    Home Microbiological Sampling in a Pediatric Cystic Fibrosis Population: Pandemic Implementation and Ongoing Use.
    Pediatr Pulmonol. 2025;60:e71378.
    PubMed     Abstract available


  192. KELCHTERMANS J, Phinizy P, Piccione J, McGrath-Morrow SA, et al
    Lower Respiratory Tract Bacterial Profiles Are Associated With Respiratory Severity and Bronchopulmonary Dysplasia in Neonates.
    Pediatr Pulmonol. 2025;60:e71364.
    PubMed     Abstract available


  193. MIEDEMA M, Yerworth R, Waldmann AD, Frerichs I, et al
    Changes in Lung Volume and Ventilation During Apnoea of Prematurity Using EIT.
    Pediatr Pulmonol. 2025;60:e71369.
    PubMed     Abstract available


  194. MYERS CW, Heerdt PM, Carlo WA, Ambalavanan N, et al
    Interactions of Patent Ductus Arteriosus and Ventilation on Preterm Pulmonary Vascular Disease.
    Pediatr Pulmonol. 2025;60:e71382.
    PubMed    


  195. GOLDEN C, Kim M, Larson K, Duncan DR, et al
    Thickened Liquids Improve Infant Swallow Function as Measured by Penetration-Aspiration Scale Score on Videofluoroscopic Swallow Study.
    Pediatr Pulmonol. 2025;60:e71363.
    PubMed     Abstract available


  196. NASR SZ, Fleifil S, Kamel TB, Nassar MF, et al
    Roadmap to Global Cystic Fibrosis Care.
    Pediatr Pulmonol. 2025;60:e71390.
    PubMed     Abstract available


  197. GEORGIOPOULOS AM, Van Citters AD, Brown CD, Yu E, et al
    Gender Differences in Mental Well-Being Among Children and Adults With Cystic Fibrosis in the Modulator Era.
    Pediatr Pulmonol. 2025;60:e71394.
    PubMed     Abstract available


  198. KALYONCU MY, Cakar NM, Arslan H, Oksay SC, et al
    Increasing Cystic Fibrosis Knowledge of Parents of Children Diagnosed With the Newborn Screening Program.
    Pediatr Pulmonol. 2025;60:e71392.
    PubMed     Abstract available


  199. CHENG SY, Sahin B, Abdulrahem N, Eckford PDW, et al
    A Review of Newborn Screening Programs for Cystic Fibrosis: Are Current Protocols Appropriate for Canada's Diverse Population?
    Pediatr Pulmonol. 2025;60:e71386.
    PubMed     Abstract available


  200. MIELGO V, Catozzi C, Ricci F, Villetti G, et al
    Caffeine Protects Newborn Rat Lungs Against the Effects of Hyperoxia and Intra-Amniotic Enterotoxin.
    Pediatr Pulmonol. 2025;60:e71395.
    PubMed     Abstract available


  201. GHEZZI M, Di Cicco M, Canali G, Lamberti R, et al
    Early Diagnosis of Non-Cystic Fibrosis Bronchiectasis in Childhood: Shedding Light on Barriers and Opportunities.
    Pediatr Pulmonol. 2025;60:e71365.
    PubMed     Abstract available


  202. MELZER LD, Vigers T, Hanley ET, Messinger A, et al
    Home Cough Monitoring Reveals Higher Nighttime Cough Burden in Children With Cystic Fibrosis Compared With Healthy Children.
    Pediatr Pulmonol. 2025;60:e71351.
    PubMed     Abstract available


  203. HOLMES M, Palladino M, Joseph Ho HY, Malajczuk CJ, et al
    Adherence to Anti-Staphylococcal Prophylaxis in the First Two Years of Life and Microbiological Outcomes in the First Six Years of Life in Children With Cystic Fibrosis.
    Pediatr Pulmonol. 2025;60:e71379.
    PubMed     Abstract available


  204. LEMYRE B, Dunn M
    Commentary on: Comparison of Bovine Lipid Extract Surfactant and Poractant Alfa Administered via LISA in Preterm Infants (28 + 0 to 34 + 6 Week) With Respiratory Distress Syndrome: A Randomized Controlled Trial.
    Pediatr Pulmonol. 2025;60:e71400.
    PubMed    


  205. AOYAMA BC, McGrath-Morrow SA, Collaco JM
    Bronchopulmonary Dysplasia Definitions As Predictors of Early Childhood Pulmonary Function.
    Pediatr Pulmonol. 2025;60:e71402.
    PubMed     Abstract available


    October 2025
  206. ZHAO T, An N, Zhu Y, Yang J, et al
    Dynamic Risk-Stratification Models for Bronchopulmonary Dysplasia in Extremely Preterm Very Low Birth Weight Infants.
    Pediatr Pulmonol. 2025;60:e71322.
    PubMed     Abstract available


  207. DURRANI NUR, Mohammed MBI, Cyprian FS, Khan MN, et al
    Antenatal Late Preterm Infants Exposure to Steroids (ALPINES) and Risk of Respiratory Distress and Hypoglycemia: A Retrospective Chart Review.
    Pediatr Pulmonol. 2025;60:e71336.
    PubMed     Abstract available


  208. DIFIGLIA S, Georgiopoulos AM, Seng EK, Portenoy R, et al
    Illness Burden in Adults With Cystic Fibrosis: Associations With Sex, Race/Ethnicity, and Socioeconomic Risk Factors.
    Pediatr Pulmonol. 2025;60:e71306.
    PubMed     Abstract available


  209. RUB DM, Napolitano N, Simmons F, Mackenzie R, et al
    Evaluating Clinically Directed Continuous Positive Airway Pressure to High Flow Nasal Cannula Transitions in Stable Preterm Infants Using Electrical Impedance Tomography: A Prospective, Observational Study.
    Pediatr Pulmonol. 2025;60:e71328.
    PubMed     Abstract available


  210. ZOU Z, Fu L, Liu J, He Y, et al
    Identification and Validation of TFF3 as a Diagnostic Biomarker and Therapeutic Agent for Bronchopulmonary Dysplasia.
    Pediatr Pulmonol. 2025;60:e71320.
    PubMed     Abstract available


  211. MOSQUERA RA, Yadav A, Romero-Lopez MDM, Magana-Ceballos IG, et al
    The Effect of Chronic Azithromycin Use in Winter on Health Care Utilization for Children With Bronchopulmonary Dysplasia: A Double Blind Randomized Controlled Study (RCT).
    Pediatr Pulmonol. 2025;60:e71314.
    PubMed     Abstract available


  212. FLEURY M, Delestrain C, Hadchouel A, Mazenq J, et al
    Phenotype-Genotype Correlations in ABCA3 Patients-The RespiRare Cohort.
    Pediatr Pulmonol. 2025;60:e71324.
    PubMed     Abstract available


  213. TERVO JP, Moore BM, DiMango E, Sadeghi H, et al
    Domain-Specific Olfaction in Children and Adults in the Era of Modulator Therapy for Cystic Fibrosis.
    Pediatr Pulmonol. 2025;60:e71348.
    PubMed     Abstract available


  214. ZAMPOLI M, Baird C, Morrow B, Verstraete J, et al
    Cystic Fibrosis Care in South Africa: Facing the Challenge of Diversity and Inequality.
    Pediatr Pulmonol. 2025;60:e71338.
    PubMed     Abstract available


  215. SAITO T, Shimokaze T, Inagaki Y, Noguchi T, et al
    Impact of Neurally Adjusted Ventilatory Assist Management on Neurodevelopmental Outcomes in Extremely Preterm Infants.
    Pediatr Pulmonol. 2025;60:e71327.
    PubMed     Abstract available


  216. NAKAZAWA Y, Ueda K, Tanahashi Y, Aoki T, et al
    Exhaled Carbon Dioxide Monitoring Using Instantaneous CO(2) Mode During High-Frequency Oscillatory Ventilation in Very Low Birth Weight Infants.
    Pediatr Pulmonol. 2025;60:e71323.
    PubMed     Abstract available


  217. PRABHAKAR N, Sri G, Bhatia A, Sodhi KS, et al
    Scimitar Syndrome: A Rare Congenital Conundrum in a Child With Stridor.
    Pediatr Pulmonol. 2025;60:e71268.
    PubMed    


  218. KUGELMAN A
    Can We Enhance Long Term Respiratory Outcomes of Neonatal Pulmonary Diseases?
    Pediatr Pulmonol. 2025;60:e71341.
    PubMed     Abstract available


  219. TSVIBAN L, Amitai N, Levine H, Jacobi E, et al
    Vaccine Coverage Among People With Cystic Fibrosis: A National Multicenter Cross-Sectional Study in Israel.
    Pediatr Pulmonol. 2025;60:e71343.
    PubMed     Abstract available


  220. ALI HA, Baiome NS, Salem YA
    Development of a Simplified Arabic Questionnaire of Health-Related Quality of Life for Children With Cystic Fibrosis.
    Pediatr Pulmonol. 2025;60:e71332.
    PubMed     Abstract available


  221. MAWLANA W, Elhady M, Alhoweiti A, Osman A, et al
    Lung Ultrasound Score as a Predictor for Extubation Failure in Preterm Infants.
    Pediatr Pulmonol. 2025;60:e71352.
    PubMed     Abstract available


  222. DUYGULU BULAN D, Dayanan R, Kahraman NC, Kunt S, et al
    Pulmonary Vascular Doppler and Fetal Lung Biometry as Predictors of Neonatal Respiratory Complications in Early- and Late-Onset Fetal Growth Restriction.
    Pediatr Pulmonol. 2025;60:e71333.
    PubMed     Abstract available


  223. SHUGG T, Gallaway KA, Powell N, Skaar TC, et al
    Enrichment of Germline Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Pathogenic Variants in Patients With Solid Tumors: Evidence for Increased Cancer Risk.
    Pediatr Pulmonol. 2025;60:e71360.
    PubMed     Abstract available


  224. SAYEDI SJ, Kheirabadi T, Zibaee S, Bakhtiari E, et al
    Effect of Camel Milk on the Spirometry Parameters of Children With Cystic Fibrosis: The First Double Blind Randomized Clinical Trial.
    Pediatr Pulmonol. 2025;60:e71298.
    PubMed     Abstract available


  225. LEE JX, Ryan ME, Sun BZ, Beam K, et al
    Predictors of Bronchodilator Response on Oscillometry and Spirometry in School-Age Children With Bronchopulmonary Dysplasia.
    Pediatr Pulmonol. 2025;60:e71359.
    PubMed     Abstract available


  226. KUMAR J, Pai K, Raghav A, Meena J, et al
    Efficacy and Safety of T-Piece Resuscitators Versus Self-Inflating Bags for Neonatal Resuscitation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Pediatr Pulmonol. 2025;60:e71354.
    PubMed     Abstract available


  227. TANG X, Chen Q, Liu Q, Chen M, et al
    Prenatal Exposure to Perfluorooctanoic Acid and Childhood Allergic Diseases: A Prospective Birth Cohort Study.
    Pediatr Pulmonol. 2025;60:e71191.
    PubMed     Abstract available


  228. GUAN Y, Wen X, Zhang X, Xu Z, et al
    Novel Pulmonary Manifestations in Pediatric Late-Onset Congenital Central Hypoventilation Syndrome: A Case Series of PHOX2B-Associated Pulmonary Hypertension and Pulmonary Alveolar Hemorrhage.
    Pediatr Pulmonol. 2025;60:e71347.
    PubMed    


    September 2025
  229. GARCIA-GOZALO M, Pellicer A, Bravo MC
    Current Practices for Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension in Neonates: A Survey Study in Spain.
    Pediatr Pulmonol. 2025;60:e71259.
    PubMed     Abstract available


  230. ALOTAIBI NZ, Lein DH, Yuen HK, Harris RA, et al
    Survey Validation of Exercise and Body Composition Testing and Exercise Training Programs for People With Cystic Fibrosis: A Delphi Study.
    Pediatr Pulmonol. 2025;60:e71262.
    PubMed     Abstract available


  231. TROST SU, Harindhanavudhi T, Wang Q, Ankireddypalli A, et al
    Elexacaftor/Tezacaftor/Ivacaftor Effect on Bone Density and Body Composition: A Retrospective Analysis.
    Pediatr Pulmonol. 2025;60:e71280.
    PubMed     Abstract available


  232. SOMBATTINA V, Nangia S, Kumar G, Bandyopadhyay T, et al
    Early (/= 37 Weeks) Neonates With Meconium Aspiration Syndrome: An Open-Label Randomized Controlled Trial.
    Pediatr Pulmonol. 2025;60:e71292.
    PubMed     Abstract available


  233. CARLIN D, Martin A, VanCliff C, Baldwin N, et al
    Caregiver Social Needs and Outpatient Respiratory Outcomes in a Cohort of Children With Bronchopulmonary Dysplasia.
    Pediatr Pulmonol. 2025;60:e71286.
    PubMed     Abstract available


  234. ZAMAL A, Sk MH, Saha B, Hazra A, et al
    Comparison of Bovine Lipid Extract Surfactant and Poractant Alfa Administered via LISA in Preterm Infants(28(+0) to 34(+6) Week) With Respiratory Distress Syndrome: A Randomized Controlled Trial.
    Pediatr Pulmonol. 2025;60:e71281.
    PubMed     Abstract available


  235. HOUSE M, Rowe J, Walters A, Liu C, et al
    Respiratory Outcomes Following Late Postnatal Dexamethasone Administration in Preterm Infants With Bronchopulmonary Dysplasia.
    Pediatr Pulmonol. 2025;60:e71275.
    PubMed     Abstract available


  236. DOLEZALOVA K, Kodetova J, Klabusayova E, Svobodova J, et al
    Beyond the Usual Suspects: Neonatal Fever and Desaturation.
    Pediatr Pulmonol. 2025;60:e71291.
    PubMed     Abstract available


  237. TSOI SM, Karvonen KL, Steurer MA, Keller RL, et al
    The Impact of Race and Ethnicity on Congenital Diaphragmatic Hernia 1-Year Mortality.
    Pediatr Pulmonol. 2025;60:e71294.
    PubMed     Abstract available


  238. GIPSMAN AI, Blanke MN, Oliver ER, Hedrick HL, et al
    Congenital Diaphragmatic Hernia Patch Infection Presenting With Digital Clubbing.
    Pediatr Pulmonol. 2025;60:e71263.
    PubMed    


  239. MURRAY LP, Zamani M, Cogen JD, Hall M, et al
    Hospitalizations in Infants and Young Children With Cystic Fibrosis Enrolled in Medicaid.
    Pediatr Pulmonol. 2025;60:e71302.
    PubMed     Abstract available


  240. HOPPE JE, Vigers T, Trujillo A, Hanley E, et al
    Impact of Home Collection and Shipping of Respiratory Specimens on Bacterial Pathogen Detection in Children With Cystic Fibrosis.
    Pediatr Pulmonol. 2025;60:e71289.
    PubMed     Abstract available


  241. WANG X, Tang Z, Wang Z
    Trends, Burden, and Inequality in Neonatal Pulmonary Arterial Hypertension: Global Estimates From 1990 to 2021.
    Pediatr Pulmonol. 2025;60:e71277.
    PubMed     Abstract available


  242. ZANNIN E, Rigotti C, Dognini G, Azzolina D, et al
    Impact of Duration of Nasal High Flow Therapy on Respiratory Outcomes in Very Preterm Infants: A Propensity Score Analysis.
    Pediatr Pulmonol. 2025;60:e71313.
    PubMed     Abstract available


  243. WANG K, Dan C, Gao S, Guang Y, et al
    Airway Administration of Budesonide Combined With Pulmonary Surfactant to Prevent Bronchopulmonary Dysplasia in Preterm Infants: A Systematic Review and Meta-Analysis.
    Pediatr Pulmonol. 2025;60:e71308.
    PubMed     Abstract available


  244. ITO M, Ohfuji S, Terui K, Nagata K, et al
    An Optimal Initial Ventilation Mode in Congenital Diaphragmatic Hernia: A Prospective Cohort Study.
    Pediatr Pulmonol. 2025;60:e71316.
    PubMed     Abstract available


  245. COTE A, Savanh P, Shalish W, Bizgu V, et al
    Caffeine for Persistent Intermittent Hypoxia in Newborns With and Without Chronic Lung Disease.
    Pediatr Pulmonol. 2025;60:e71312.
    PubMed     Abstract available


  246. ROLLO G, Zarfati A, Burini G, Valfre L, et al
    Persistent Low-Output Neonatal Chylothorax: How Long Are We Justified to Wait for Pleurodesis in Partial Responders?
    Pediatr Pulmonol. 2025;60:e71311.
    PubMed     Abstract available


    August 2025
  247. OATES GR, Riekert KA, Ford C, Dickinson KM, et al
    Associations Between Socioeconomic Status and Adherence to Medications in People With Cystic Fibrosis.
    Pediatr Pulmonol. 2025;60:e71230.
    PubMed     Abstract available


  248. TILLMAN EM, McKinzie C, Young D, Kam C, et al
    Current State of Pharmacogenomic Implementation Into Care for Persons With Cystic Fibrosis.
    Pediatr Pulmonol. 2025;60:e71229.
    PubMed     Abstract available


  249. SANCHEZ-SOLANO NJ, Wall TJ, Barton GP, Dane DM, et al
    Lung Function in a Multiethnic U.S. Cohort of Adolescents and Adults Born Preterm in the New BPD Era.
    Pediatr Pulmonol. 2025;60:e71226.
    PubMed     Abstract available


  250. PETTIT RS, Howell K, Langhorst J, Flora CC, et al
    Impact of Number of Pharmacies on Dornase Alfa Medication Possession Ratio in Children With Cystic Fibrosis.
    Pediatr Pulmonol. 2025;60:e71231.
    PubMed     Abstract available


  251. SAVANT AP
    Cystic Fibrosis Year in Review 2024.
    Pediatr Pulmonol. 2025;60:e71222.
    PubMed     Abstract available


  252. DUDOIGNON B, Abdelkarim R, Delclaux C, Bokov P, et al
    Is Positive Airway Pressure Lab-Titration Always Necessary to Start Noninvasive Respiratory Support in Infants?
    Pediatr Pulmonol. 2025;60:e71233.
    PubMed     Abstract available


  253. POGGI C, Fusco M, Sassudelli G, Corsini I, et al
    Prediction of Bronchopulmonary Dysplasia by Diaphragmatic Ultrasound in Preterm Infants: A Prospective Pilot Study.
    Pediatr Pulmonol. 2025;60:e71243.
    PubMed     Abstract available


  254. CHOTZOGLOU E, Prasath A, Desai R, David L, et al
    Effectiveness of A Respiratory Care Protocol Including Less Invasive Surfactant Administration in >/= 35 Weeks Gestational Age Infants.
    Pediatr Pulmonol. 2025;60:e71257.
    PubMed     Abstract available


  255. ANDINA MARTINEZ D, Claret Teruel G, Gijon Mediavilla M, Fernandez Mozo E, et al
    Nirsevimab and Acute Bronchiolitis Admissions in Infants Under One Year of Age.
    Pediatr Pulmonol. 2025;60:e71249.
    PubMed     Abstract available


  256. YANG K, Sun W, Wang B
    Crystal Ball or Compass? Navigating the Clinical Use of Predictive Models in Neonatal Care.
    Pediatr Pulmonol. 2025;60:e71248.
    PubMed    


  257. GUENTHER CS, Chiel LE, Dy FJ, Lee EY, et al
    Thinking Fast: Addressing a Tachypneic Infant.
    Pediatr Pulmonol. 2025;60:e71238.
    PubMed    


  258. ANNE-MARIE DP, Leah G, Nyathi NM, Stephanie GR, et al
    Correlation of High Resolution CT Findings With Lung Function in Adolescents With Perinatally Acquired HIV on Anti-Retroviral Therapy.
    Pediatr Pulmonol. 2025;60:e71234.
    PubMed     Abstract available


  259. CARTY L, Dobra R, Francis J, Puckey M, et al
    Qualitative Experiences and Depression/Anxiety Scores in Parents of Children With Cystic Fibrosis Transmembrane Conductance Regulator Related Metabolic Syndrome.
    Pediatr Pulmonol. 2025;60:e71224.
    PubMed     Abstract available


  260. HOLCIK S, Hawayi L, Dussah N, Barrowman N, et al
    Risk Factors for Severe Respiratory Morbidity at 2 Years of Life in Children Born Extremely Preterm With Bronchopulmonary Dysplasia.
    Pediatr Pulmonol. 2025;60:e71258.
    PubMed     Abstract available


  261. YUCE OZDEMIR H, Mumusoglu S, Kalyoncu AF, Damadoglu E, et al
    Knowledge, Attitudes, and Behaviors of Cystic Fibrosis Patients on Reproductive Health in Turkiye.
    Pediatr Pulmonol. 2025;60:e71247.
    PubMed     Abstract available


  262. DIPPEL CM, Sohrabi K, Takoulegha D, Ehrhardt H, et al
    Effects of Short Versus Prolonged Inspiratory Times on Oxygen Saturation Targeting in Very Low Birth Weight Infants During Synchronized NIPPV.
    Pediatr Pulmonol. 2025;60:e71250.
    PubMed     Abstract available


  263. SAITO T, Maruyama Y, Miyosawa Y, Hirabayashi K, et al
    Efficacy of Noninvasive Neurally Adjusted Ventilatory Assist (NIV-NAVA) for Neonates With Transient Tachypnea of the Newborn: A Retrospective Analysis.
    Pediatr Pulmonol. 2025;60:e71246.
    PubMed     Abstract available


  264. AZAM A, Barry PJ, Bright-Thomas RJ, Horsley A, et al
    The Impact of Attention Deficit Hyperactivity Disorder on Home Spirometry and Other Parameters in People With Cystic Fibrosis.
    Pediatr Pulmonol. 2025;60:e71266.
    PubMed     Abstract available


  265. YILDIZ CA, Selcuk Balci M, Kocakaya D, Cinar C, et al
    Healthy Homes, Healthy Lungs: The Role of Home Insulation in Environmental Impact on People With Cystic Fibrosis.
    Pediatr Pulmonol. 2025;60:e71253.
    PubMed     Abstract available


  266. MOORE CE, Chen W, Bichl S, Wong A, et al
    Utility of Continuous Glucose Monitors for Improved Detection of Cystic Fibrosis-Related Diabetes.
    Pediatr Pulmonol. 2025;60:e71267.
    PubMed     Abstract available


  267. BRUMER E, Shabanova V, Urbach H, Montgomery A, et al
    Bronchopulmonary Dysplasia in the First Year: Insights Into Severity, Medication Use, and Healthcare Utilization.
    Pediatr Pulmonol. 2025;60:e71254.
    PubMed     Abstract available


    July 2025
  268. SCHOOP AC, Denz R, Maier C, Brinkmann F, et al
    Randomized Cross-Over Analysis of the Influence of Nitrogen Multiple Breath Washout on Spirometry in Monitoring Lung Function in Patients With Cystic Fibrosis and Primary Ciliary Dyskinesia.
    Pediatr Pulmonol. 2025;60:e71189.
    PubMed     Abstract available


  269. YASUI M, Ogihara T, Yamaoka S, Shinohara J, et al
    The Reference Interval for the Attainment of Comparable Term Functional Levels of Pulmonary Oxygenation Capacity in Healthy Preterm Infants: A Single-Center Retrospective Study.
    Pediatr Pulmonol. 2025;60:e71182.
    PubMed     Abstract available


  270. NENNA R, Petrarca L, Conti MG, Mancino E, et al
    Blood Neutrophils in Infants Admitted for Bronchiolitis and Subsequent Lung Function Impairment.
    Pediatr Pulmonol. 2025;60:e71058.
    PubMed    


  271. ZANNIN E, Rigotti C, Robbiani S, Dellaca RL, et al
    Temperature and Humidity During Different Neonatal Respiratory Support Modes: An In-Vitro Performance of Four Heated Humidifiers.
    Pediatr Pulmonol. 2025;60:e71184.
    PubMed     Abstract available


  272. HORNE RSC, Yee AK, Siriwardhana LS, Walter LM, et al
    Long Term Developmental Consequences of Short Apneas and Periodic Breathing in Preterm Infants.
    Pediatr Pulmonol. 2025;60:e71193.
    PubMed     Abstract available


  273. LOZANO-RAY E, Argent AC, Lupton-Smith A, Morrow BM, et al
    The Effect of Limiting Anterior Chest Wall Movement With a Weighted Blanket on Comfort, Oxygenation, and Ventilation Homogeneity in Nonventilated Infants and Children Admitted to Hospital With Lower Respiratory Tract Infections: An Exploratory Pilot S
    Pediatr Pulmonol. 2025;60:e71186.
    PubMed     Abstract available


  274. CHOUROU H, Ben Aziza R, Bourcheda M, Sdiri Y, et al
    Congenital Pulmonary Airway Malformations: Experience of a Tunisian Tertiary Referral Center Over a Five-Year Period.
    Pediatr Pulmonol. 2025;60:e71188.
    PubMed     Abstract available


  275. KARTAL OZTURK G, Halis E, Ocak E, Eski A, et al
    Exploring Bone Health in Cystic Fibrosis: A Study From a Lung Transplantation Center and Strategy for Clinical Care.
    Pediatr Pulmonol. 2025;60:e71210.
    PubMed     Abstract available


  276. CHEMALI D, Fleischer E, Uyeno R, Mullowney T, et al
    Variations in the Management of Canadian Patients With CFTR Related Metabolic Syndrome/Cystic Fibrosis Screen Positive, Inconclusive Diagnosis (CRMS/CFSPID).
    Pediatr Pulmonol. 2025;60:e71200.
    PubMed     Abstract available


  277. RAIMONDI F, Dolce P, Veropalumbo C, Sierchio E, et al
    A Simplified, Regional Lung Ultrasound Score for Surfactant Administration in Neonatal RDS: A Prospective Observational Study.
    Pediatr Pulmonol. 2025;60:e71206.
    PubMed     Abstract available


  278. ERNEST TE, Ozalvo D, Staretz-Chacham O, Marks KA, et al
    Predischarge Betamethasone in Infants Diagnosed With Bronchopulmonary Dysplasia.
    Pediatr Pulmonol. 2025;60:e71201.
    PubMed     Abstract available


  279. HERGENROEDER GE, Psoter KJ, Brown CD, Ostrenga J, et al
    Baseline Characteristics and Self-Reported Use of Chronic Daily Therapies of the Home Reported Outcomes With CFTR Modulator Therapy (HERO-2) Cohort.
    Pediatr Pulmonol. 2025;60:e71190.
    PubMed     Abstract available


  280. PASTEKA R, Hufnagl L, Vodenicharov V, Blessing A, et al
    Surfactant Delivery Is Crucial for Enhancing Function of Ex-Vivo Premature Sheep Lungs: A Feasibility Study.
    Pediatr Pulmonol. 2025;60:e71205.
    PubMed     Abstract available


  281. LONABAUGH KP, Saulitis A, Boettinger E, Brighton D, et al
    Improving Modulator Management and Side Effect Screening: A CF Learning Network Innovation Lab.
    Pediatr Pulmonol. 2025;60:e71187.
    PubMed     Abstract available


  282. SMITH JS, Coffey MJ, Jaffe A, Chuang S, et al
    Disorders of Gut-Brain Interaction in a Pediatric Cystic Fibrosis Cohort.
    Pediatr Pulmonol. 2025;60:e71214.
    PubMed     Abstract available


  283. KUMAR P, Goyal JP, Bhat JI, Dhochak N, et al
    Microbiological Profile of Airway in Indian Children With Cystic Fibrosis: A Multicenter Prospective Cohort Study.
    Pediatr Pulmonol. 2025;60:e71194.
    PubMed     Abstract available


  284. RODRIGUEZ-MARTINEZ CE, Midulla F, Nino G
    Viral Bronchiolitis in Infants in the Era of Targeted Therapies: What Now and What's Next?
    Pediatr Pulmonol. 2025;60:e71215.
    PubMed     Abstract available


  285. LIU TW, Huang SY, Chou CM, Lin CH, et al
    The Association Between the Surgical Timing for Congenital Malformation of Lung and Asthma Prevalence-A Nationwide Cohort Study.
    Pediatr Pulmonol. 2025;60:e71225.
    PubMed     Abstract available


  286. GATES Q, Ehwerhemuepha L, Janardhan S, Joshi R, et al
    Early Prediction of Mechanical Ventilation Needs in Very Preterm Neonates Using Machine Learning.
    Pediatr Pulmonol. 2025;60:e71195.
    PubMed     Abstract available


    June 2025
  287. SINGH R, Ojha V, Faisal NV, Kumar S, et al
    Innominate Artery Compression Syndrome in an Infant With Acyanotic Congenital Heart Disease.
    Pediatr Pulmonol. 2025;60:e71141.
    PubMed    


  288. URBACH H, Ostfeld-Johns S, McCollum S, Weiss P, et al
    Social Determinants of Health and Healthcare Utilization in Infants With Bronchopulmonary Dysplasia.
    Pediatr Pulmonol. 2025;60:e71153.
    PubMed     Abstract available


  289. SUNMAN B, Yalcin E, Erdal MA, Sen V, et al
    Impact of Modulator Therapy on the Chronic Colonization of Lower Respiratory Tract Pathogens in Children: Data From Cystic Fibrosis Registry of Turkey.
    Pediatr Pulmonol. 2025;60:e71155.
    PubMed     Abstract available


  290. RAJVANSHI N, Ks A, Kumar TVV
    The Inverted Steeple Sign, Tracheal Tug, and Biphasic Stridor: A Triad for Diagnosing Congenital Tracheal Stenosis.
    Pediatr Pulmonol. 2025;60:e71151.
    PubMed    


  291. KAZMERSKI TM, Kidd KM, Jain R, Jathal I, et al
    Investigating the Interplay Between Having Cystic Fibrosis and Being a Member of the LGBTQIA+ Community: Protocol for the PRIDE CF Study.
    Pediatr Pulmonol. 2025;60:e71154.
    PubMed     Abstract available


  292. GOVER A, Smolkin T, Molad M, Lavie-Nevo K, et al
    HHHFNC Versus NIPPV Delivered by Long Narrow Cannula in Preterm Infants: Randomized Noninferiority Trial.
    Pediatr Pulmonol. 2025;60:e71167.
    PubMed     Abstract available


  293. SANKARARAMAN S, Prunty L, Pamer C, Thavamani A, et al
    Impact of Elexacaftor/Tezacaftor/Ivacaftor on Fecal Elastase-1 in Children With Cystic Fibrosis.
    Pediatr Pulmonol. 2025;60:e71156.
    PubMed     Abstract available


  294. TRAVERS CP, Gentle SJ, Shukla VV, Aban I, et al
    Late Permissive Hypercapnia for Mechanically Ventilated Preterm Infants: A Randomized Trial.
    Pediatr Pulmonol. 2025;60:e71165.
    PubMed     Abstract available


  295. RIGGSBEE D, Pettit RS
    Safety of Inhaled Tobramycin for Pseudomonas Eradication in People With Cystic Fibrosis Less Than 1 Year of Age.
    Pediatr Pulmonol. 2025;60:e71162.
    PubMed     Abstract available


  296. XIE B, Xiang L
    An Ultra Protective Ventilation Bundle in an Infancy Severe pARDS Post Liver Transplantation.
    Pediatr Pulmonol. 2025;60:e71172.
    PubMed    


  297. ALEKSANDER PE, Thee S, Doellinger F, Zagkla S, et al
    Prenatal Elexacaftor/Tezacaftor/Ivacaftor Treatment Prevents Meconium Ileus, but Not Exocrine Pancreatic Insufficiency and Lung Disease in Infants With Cystic Fibrosis.
    Pediatr Pulmonol. 2025;60:e71168.
    PubMed    


  298. WRIGHT BA, Godfrey KC, Gryp EE, Harklau NM, et al
    Fueling Health: Overcoming Food Barriers in Cystic Fibrosis Care.
    Pediatr Pulmonol. 2025;60:e71177.
    PubMed     Abstract available


  299. HASEBE M, Ogawa R, Arimitsu T, Namba F, et al
    Impact of Home Oxygen Therapy for Bronchopulmonary Dysplasia on Families With Neonates: A Survey Conducted in Japan.
    Pediatr Pulmonol. 2025;60:e71179.
    PubMed     Abstract available


  300. FRIEDMAN D, Quittner AL, He J, Chaudhary N, et al
    Preliminary Psychometric Characteristics of the Cystic Fibrosis Coping Self-Efficacy (CF-CSE) Scale.
    Pediatr Pulmonol. 2025;60:e71164.
    PubMed     Abstract available


  301. LYNCH J, Jensen R, Shaw M, Dumas MP, et al
    Feasibility and Utility of Multiple Breath Washout Measured Scond and Sacin in Preschool Children With Cystic Fibrosis.
    Pediatr Pulmonol. 2025;60:e71180.
    PubMed     Abstract available


  302. HENRIKSEN EH, Sandvik RM, Olsen MF, Pressler T, et al
    Real-World Improvements of Lung Clearance Index and Ventilation Distribution Efficiency in Children With Cystic Fibrosis After Elexacaftor/Tezacaftor/Ivacaftor Initiation.
    Pediatr Pulmonol. 2025;60:e71166.
    PubMed     Abstract available


    May 2025
  303. HEFFERNAN ME, Barrera L, Jones M, Hayes A, et al
    The Newborn Screening Experience of Caregivers of Children With Cystic Fibrosis in the United States: A Cross-Sectional Survey.
    Pediatr Pulmonol. 2025;60:e71110.
    PubMed     Abstract available


  304. ARIGLIANI M, Chaudhry S, Brugha R, Suri R, et al
    Infant Lung Function in Cystic Fibrosis: A Real-World Study.
    Pediatr Pulmonol. 2025;60:e71117.
    PubMed     Abstract available


  305. ALBON D, Ong T, Horton B, Brighton D, et al
    Cystic Fibrosis Learning Network Telehealth Innovation Lab During the COVID-19 Pandemic: Impact on Access to Care, Outcomes, and a New CF Care Model.
    Pediatr Pulmonol. 2025;60:e71102.
    PubMed     Abstract available


  306. KOCAMAN D, Yildiz CA, Metin Cakar N, Uzunoglu B, et al
    Feeding the Need: A Study on Food Security Among People With Cystic Fibrosis in Turkey.
    Pediatr Pulmonol. 2025;60:e71101.
    PubMed     Abstract available


  307. CAKAR MK, Uytun S, Gencoglu MY, Soydas SSA, et al
    A Rare Cause of Interstitial Lung Disease in Infancy: CCR2 Gene.
    Pediatr Pulmonol. 2025;60:e71116.
    PubMed    


  308. PAL S, Ghosh M
    Risk Factors and Prediction Models for Less Invasive Surfactant Administration Failure in Preterm Infants: A Retrospective Cohort Study in a Low-and-Middle Income Country.
    Pediatr Pulmonol. 2025;60:e71127.
    PubMed     Abstract available


  309. STOECKLIN B, Al-Obaidi Z, Svedenkrans J, Dellaca R, et al
    Diaphragm Function in Very Preterm Infants at 36 Weeks' Postmenstrual Age.
    Pediatr Pulmonol. 2025;60:e71121.
    PubMed     Abstract available


  310. BARBER AT, Davis SD, Ferkol TW, Shapiro AJ, et al
    The Association of Neonatal Respiratory Distress With Ciliary Ultrastructure and Genotype in Primary Ciliary Dyskinesia.
    Pediatr Pulmonol. 2025;60:e71091.
    PubMed     Abstract available


  311. HOSHINO Y, Arai J, Hirono K, Maruo K, et al
    Impact of Sedation on Ventilator-Induced Diaphragmatic Dysfunction in Extremely Preterm Infants.
    Pediatr Pulmonol. 2025;60:e71126.
    PubMed     Abstract available


  312. LEYENS J, Schroeder L, Salatsch C, Schmitt J, et al
    Flexible Bronchoscopy in Neonates With Congenital Diaphragmatic Hernia.
    Pediatr Pulmonol. 2025;60:e71128.
    PubMed     Abstract available


  313. DIJKMAN KP, Delbressine JJ, Dieleman JP, Mohns T, et al
    Continuous Application of Closed-Loop FiO2-Control in Extremely Preterm Infants: A Matched Cohort Single-Center Study.
    Pediatr Pulmonol. 2025;60:e71122.
    PubMed     Abstract available


  314. GUYOT E, Deygas F, Belhassen M, Berard M, et al
    Newborn Screening for Cystic Fibrosis Is Associated With the Lowest Healthcare Costs: A 10-Year Observational Follow-Up Study in France.
    Pediatr Pulmonol. 2025;60:e71134.
    PubMed     Abstract available


  315. RICHARD K, D'Anna R, Dahlberg SE, White H, et al
    Impact of Social Determinants on Home Oxygen Therapy Duration in Preterm Infants: A Study Utilizing the Childhood Opportunity Index.
    Pediatr Pulmonol. 2025;60:e71132.
    PubMed     Abstract available


  316. SAARIKALLIO S, Riikonen R, Tikkakoski A, Laitinen S, et al
    Bronchiolitis in Early Infancy Is Associated With Irreversible Airway Obstruction in Young Adulthood.
    Pediatr Pulmonol. 2025;60:e71139.
    PubMed     Abstract available


  317. DETAR M, Szasz B, Barta H, Szabo M, et al
    End-Tidal Carbon Dioxide Monitoring in Neonates Receiving Therapeutic Hypothermia for Hypoxic-Ischemic Encephalopathy.
    Pediatr Pulmonol. 2025;60:e71144.
    PubMed     Abstract available


    April 2025
  318. RUBIA-ORTEGA S, Regiroli G, Vivalda L, Loi B, et al
    Whole Body Hypothermia and Lung Aeration in Meconium Aspiration-Induced Neonatal ARDS.
    Pediatr Pulmonol. 2025;60:e71074.
    PubMed    


  319. DUDOIGNON B, Bokov P, Benterki F, Couque N, et al
    Reliability of Composite Autonomic Symptom Score (COMPASS)-31 in Congenital Central Hypoventilation Syndrome.
    Pediatr Pulmonol. 2025;60:e71072.
    PubMed     Abstract available


  320. RAHTU M, Frerichs I, Becher TH, Pokka T, et al
    Changes in Respiratory Patterns From Pressure Control Ventilation to Neurally Adjusted Ventilatory Assist Assessed by Electrical Impedance Tomography.
    Pediatr Pulmonol. 2025;60:e71077.
    PubMed     Abstract available


  321. DOTAN M, Trau M, Mei-Zahav M, Mussaffi H, et al
    Pancreatic Status Is Not a Risk Factor for Cystic Fibrosis-Related Bone Disease.
    Pediatr Pulmonol. 2025;60:e71078.
    PubMed     Abstract available


  322. GRUBER W, Koop J, Haegele FA, Falkenberg C, et al
    Effects of an Exercise Intervention on Exercise Capacity in Adults With Cystic Fibrosis: A Quasi-Experimental Study Comparing Individuals Treated With and Without Elexacaftor/Tezacaftor/Ivacaftor.
    Pediatr Pulmonol. 2025;60:e71076.
    PubMed     Abstract available


  323. COTE-CORRIVEAU G, Lasry A, Begin P, Bilodeau-Bertrand M, et al
    Respiratory Related Hospitalization in Children With Exposure to Meconium Aspiration or Staining.
    Pediatr Pulmonol. 2025;60:e71085.
    PubMed     Abstract available


  324. JOHNSON ED, Boss RD, Park WY, Aziz KB, et al
    Time Toxicity: Quantifying Healthcare Utilization Attributable to Pediatric Home Ventilation.
    Pediatr Pulmonol. 2025;60:e71081.
    PubMed     Abstract available


  325. ANZINGER FX, Hashagen TJ, Palaniappan P, Lindner A, et al
    Comparative Analysis of Analog and Digital Chest Tube Drainage Systems Using a High-Fidelity 3D-Printed Neonatal Chest Model.
    Pediatr Pulmonol. 2025;60:e71090.
    PubMed     Abstract available


  326. SINDELAR R, Ehrhardt H
    Uncovering the Physiologic Basis of Improved Oxygenation during Prone Positioning in Preterm Infants.
    Pediatr Pulmonol. 2025;60:e71086.
    PubMed    


  327. BARKA K, Papachatzi E, Fouzas S, Dimitriou G, et al
    Respiratory Function in Ventilated Newborn Infants Nursed Prone and Supine.
    Pediatr Pulmonol. 2025;60:e71075.
    PubMed     Abstract available


  328. BANSAL M, Manimtim WM, Agarwal A, Alexiou S, et al
    Outcomes of Ventilator-Dependent Children With Severe Bronchopulmonary Dysplasia and Tracheobronchomalacia.
    Pediatr Pulmonol. 2025;60:e71100.
    PubMed     Abstract available


  329. FRIEDMAN D, Mullen TMD, Behrman M, Nikravan L, et al
    "How Do You Live the Best Life You Can With This Pain?" A Qualitative Study of Adults Living With CF and Pain in the Modulator ERA.
    Pediatr Pulmonol. 2025;60:e71087.
    PubMed     Abstract available


  330. LAEGSGAARD E, Thim SB, Holm M, Rubak S, et al
    COVID-19 in Children With Severe Lung Disease-A Tertiary Center Cohort Study in Denmark.
    Pediatr Pulmonol. 2025;60:e71094.
    PubMed     Abstract available


  331. MORTAMET G, Milesi C, Cassibba J, Ego A, et al
    Noninvasive Respiratory Support Weaning in Infants With Severe Bronchiolitis: High Flow Nasal Cannula May Reduce the Length of Stay.
    Pediatr Pulmonol. 2025;60:e71108.
    PubMed     Abstract available


  332. ABDELGHANI A, Cuneo A, Gibb E, Perito ER, et al
    Identifying Gaps and Disparities in Screening for Cystic Fibrosis Associated Liver Disease: Insights From a CF Center Analysis.
    Pediatr Pulmonol. 2025;60:e71097.
    PubMed     Abstract available


    March 2025
  333. VERKLEIJ M, Vlieg-Boerstra B, Hofsteenge GH, Haarman E, et al
    The Dutch Gastrointestinal Symptom Tracker for People With Cystic Fibrosis: Associations With Anxiety, Depression, and Health-Related Quality of Life.
    Pediatr Pulmonol. 2025;60:e71021.
    PubMed     Abstract available


  334. VAZIRI S, McGarry ME, Cuneo AA, Willen SM, et al
    A Joint Conversation: People With Cystic Fibrosis' Perception of Healthcare Teams' Knowledge, Comfort, and Barriers in Discussing Substance Use.
    Pediatr Pulmonol. 2025;60:e71017.
    PubMed     Abstract available


  335. FIREIZEN Y, Ahmed M, Vigers T, Akong K, et al
    Changing Epidemiology of Pediatric Pulmonary Exacerbations in Cystic Fibrosis.
    Pediatr Pulmonol. 2025;60:e71019.
    PubMed     Abstract available


  336. LEON C, Kawatra P, Martin A, Aoyama B, et al
    Outpatient Respiratory Outcomes in Extremely Preterm Children During the First 3 Years of Life.
    Pediatr Pulmonol. 2025;60:e71025.
    PubMed     Abstract available


  337. LIU W, Wei H, Xiang L, Liu Y, et al
    Bridging the Gap in Neonatal Care: Evaluating AI Chatbots for Chronic Neonatal Lung Disease and Home Oxygen Therapy Management.
    Pediatr Pulmonol. 2025;60:e71020.
    PubMed     Abstract available


  338. HAYDEN HS, Nelson MT, Ross SE, Verster AJ, et al
    Effects of Therapeutic Antibiotic Exposure on the Oropharyngeal and Fecal Microbiota in Infants With Cystic Fibrosis.
    Pediatr Pulmonol. 2025;60:e71024.
    PubMed     Abstract available


  339. DOMANY KA, Mandelberg A, Burrack N, Golan-Tripto I, et al
    Respiratory Syncytial Virus Burden in Premature Infants: The Role of Season With and Without RSV Immunoprophylaxis in a Multicenter Study.
    Pediatr Pulmonol. 2025;60:e71022.
    PubMed     Abstract available


  340. CLAYTON LJ, Shepherd AI, Corbett J, Gruet M, et al
    Peripheral Muscle Function and Body Composition in People With Cystic Fibrosis on Elexacaftor/Tezacaftor/Ivacaftor: A Cross-Sectional Single-Centre Study.
    Pediatr Pulmonol. 2025;60:e71044.
    PubMed     Abstract available


  341. HUANG L, Lai HJ, Furuya KN, Antos NJ, et al
    The Frequency and Potential Implications of HFE Genetic Variants in Children With Cystic Fibrosis.
    Pediatr Pulmonol. 2025;60:e71042.
    PubMed     Abstract available


  342. WILLIAMS CL, Billings J, McGowan H, McDevitt R, et al
    Impact of Elexacaftor/Tezacaftor/Ivacaftor on Microbiology and Antibiotic Utilization in People With Cystic Fibrosis.
    Pediatr Pulmonol. 2025;60:e71038.
    PubMed     Abstract available


  343. UZUNOGLU B, Selcuk Balci M, Kalyoncu M, Karabulut S, et al
    Elexacaftor/Tezacaftor/Ivacaftor Treatment Accessibility and Mental Health: Reducing Anxiety in People With Cystic Fibrosis.
    Pediatr Pulmonol. 2025;60:e71037.
    PubMed     Abstract available


  344. MORAKEAS S, Tracy MB, Hinder M, Gruber V, et al
    Does Leak Matter? A Novel Dynamic Leak Model to Simulate Leak for Performance Testing of Manual Neonatal Resuscitation Devices. A Bench Study.
    Pediatr Pulmonol. 2025;60:e71043.
    PubMed     Abstract available


  345. ARPINI LDSB, Liberato FMG, Paro FM, Santos SDS, et al
    Genetic Variants and Clinical Characteristics in the Diagnosis of Children Aged Under 18 Years With Cystic Fibrosis in a Brazilian State.
    Pediatr Pulmonol. 2025;60:e71048.
    PubMed     Abstract available


  346. KEREM E
    Expanding the Impact of New Cystic Fibrosis Therapies in Low- and Middle-Income Countries.
    Pediatr Pulmonol. 2025;60 Suppl 1.
    PubMed     Abstract available


  347. COHEN-CYMBERKNOH M
    Advances in the restoration of CFTR in children and pwCF with "mild disease".
    Pediatr Pulmonol. 2025;60 Suppl 1.
    PubMed     Abstract available


  348. COHEN-CYMBERKNOH M
    Infection and Inflammation in the Cystic fibrosis (CF) airway.
    Pediatr Pulmonol. 2025;60 Suppl 1.
    PubMed     Abstract available


  349. RATJEN F
    The future of cystic fibrosis: A global perspective.
    Pediatr Pulmonol. 2025;60 Suppl 1:S75-S76.
    PubMed     Abstract available


  350. FORNO E
    Integrating genomics as clinical biomarkers in pediatric pulmonology.
    Pediatr Pulmonol. 2025;60 Suppl 1.
    PubMed     Abstract available


  351. KABRA SK
    Challenges in the care of cystic fibrosis in low-to-middle income countries.
    Pediatr Pulmonol. 2025;60 Suppl 1:S48-S50.
    PubMed     Abstract available


  352. RAND CM, Pelissou J, Krishnamurthi N, Chapelle XP, et al
    Congenital Central Hypoventilation Syndrome (CCHS): Patient Quality of Life and Caregiver Burden.
    Pediatr Pulmonol. 2025;60:e71012.
    PubMed     Abstract available


  353. SOLARSKA-RYDZ K, Marczak H, Kulus M, Krenke K, et al
    A Novel Treatment of STING-Associated Vasculopathy With Onset in Infancy.
    Pediatr Pulmonol. 2025;60:e71052.
    PubMed    


    February 2025
  354. GRAPSY J, Ueng CS, Patel K, Dassner A, et al
    Initial Antibiotic Selection Based on Microbiologic History in Pediatric Cystic Fibrosis-Related Pulmonary Exacerbations.
    Pediatr Pulmonol. 2025;60:e27491.
    PubMed     Abstract available


  355. BALCI MS, Gokdemir Y, Eralp EE, Ergenekon AP, et al
    Implementation of Cystic Fibrosis Responsibility, Independence, Self-Care, Education Program Enhances Cystic Fibrosis Knowledge in Limited Resource Country: Results From a Randomized Controlled Trial.
    Pediatr Pulmonol. 2025;60:e27506.
    PubMed     Abstract available


  356. ILHAN O, Celik K, Ozkan NZ, Kocaoglu I, et al
    Nasal Intermittent Positive Pressure Ventilation During Neonatal Endotracheal Intubation: A Randomized Controlled Trial.
    Pediatr Pulmonol. 2025;60:e27512.
    PubMed     Abstract available


  357. KAMBARA M, Takeuchi J, Kumano A, Fujita C, et al
    Postmenstrual age at Extubation as a Risk Factor Associated With Respiratory-Related Reintubation Among Extremely Preterm Infants: A Retrospective Cohort Study.
    Pediatr Pulmonol. 2025;60:e27500.
    PubMed     Abstract available


  358. DUDECK B, Abebe EW, Sun W, Gaskin PR, et al
    Modifiable and Non-Modifiable Risk Factors for Tracheostomy in Preterm Infants.
    Pediatr Pulmonol. 2025;60:e71005.
    PubMed     Abstract available


  359. CONDIT PE, Hokanson JS, Balasubramaniam V, McCulley DJ, et al
    Risk Factors Associated With the Development of Late Pulmonary Artery Hypertension in Extremely Premature Infants.
    Pediatr Pulmonol. 2025;60:e27501.
    PubMed     Abstract available


  360. GAUTAM NK, H A V, Pejaver R, Nagesh K, et al
    Diagnostic Utility of Bedside "Point of Care Lung Ultrasound" in Predicting the Need For NICU Admission in Late Preterm and Term Newborns Having Respiratory Distress Soon After Birth in the Transition Period: A Prospective Observational Study.
    Pediatr Pulmonol. 2025;60:e71000.
    PubMed     Abstract available


  361. SCHNEIDER-FUTSCHIK EK, Munro CB, Quinlan C, Ranganathan S, et al
    Investigating the Potential Hearing Impairment and Ototoxicity in Children up to Six Years With Cystic Fibrosis After Aminoglycoside Exposure (PIANO-CF Extension).
    Pediatr Pulmonol. 2025;60:e27505.
    PubMed     Abstract available


  362. FORCELLINI CA, Rossignoli S, Ficial B, Cenci G, et al
    A Refined Score, Namely Thoracic Ultrasound Score, to Predict the Need for Surfactant in Preterm Neonates: A Prospective, Multicenter, Observational Study.
    Pediatr Pulmonol. 2025;60:e71001.
    PubMed     Abstract available


  363. MASOLINI M, Ferrari B, Castellani C, Calogero C, et al
    Efficacy of Intrapulmonary Percussive Ventilation in a Newborn With Primary Ciliary Dyskinesia.
    Pediatr Pulmonol. 2025;60:e70995.
    PubMed    


  364. AKKAYA A, Ilhan O, Kocaoglu I, Hakan N, et al
    Comparison of Three Methods in Estimating the Oral Endotracheal Tube Insertion Depth in Neonates: Nasal Septum-Tragus Length, Weight, or Gestation? A Randomized Trial.
    Pediatr Pulmonol. 2025;60:e70992.
    PubMed     Abstract available


  365. DAVIS J, Perkins R, Bailey J, Chaudary N, et al
    Acceptability of Telehealth Post-Pandemic Among Clinicians Across the United States Caring for People With Cystic Fibrosis.
    Pediatr Pulmonol. 2025;60:e70000.
    PubMed     Abstract available


  366. AKSOY M, Memur S, Yasa B, Cetinkaya M, et al
    A Novel and Promising Method for Prediction of Early Surfactant Requirement in Preterm Infants With Respiratory Distress Syndrome: Pulmonary Near-Infrared Spectroscopy.
    Pediatr Pulmonol. 2025;60:e71023.
    PubMed     Abstract available


  367. MACATANGAY NJ, Engdahl S, Pettit RS
    Tobramycin Pharmacokinetics in Pediatric Patients With Primary Ciliary Dyskinesia.
    Pediatr Pulmonol. 2025;60:e71018.
    PubMed     Abstract available


    January 2025
  368. HUANG RL, Snyder MT, Fahmida N, Albon DP, et al
    Reconsidering the Diagnosis: Abnormal Sweat Chloride Tests in Non-CF Bronchiectasis.
    Pediatr Pulmonol. 2025 Jan 7:e27471. doi: 10.1002/ppul.27471.
    PubMed     Abstract available


  369. ZWITSERLOOT AM, Aziz SZ, Chen Y, Bannier MAGE, et al
    Introduction of Ivacaftor/Lumacaftor in Children With Cystic Fibrosis Homozygous for F508del in the Netherlands: A Nationwide Real-Life Study.
    Pediatr Pulmonol. 2025;60:e27473.
    PubMed     Abstract available


  370. ZIRBES CF, Feder A, Pamatmat AJ, Bartels AR, et al
    Genetic Concordance of Staphylococcus aureus From Oropharyngeal and Sputum Cultures in People With Cystic Fibrosis.
    Pediatr Pulmonol. 2025;60:e27475.
    PubMed     Abstract available


  371. MOORE PE, Hayden LP, Villafranco NM, Toprak D, et al
    Outpatient clinical care for bronchopulmonary dysplasia: A survey of the BPD collaborative.
    Pediatr Pulmonol. 2025;60:e27296.
    PubMed     Abstract available


  372. VERWEY C, Sojib HGK, Islam MS, Roy AD, et al
    Pulmonary Function Testing in Healthy Infants in Rural Bangladesh: Feasibility Study.
    Pediatr Pulmonol. 2025;60:e27461.
    PubMed     Abstract available


  373. SAPRU K, Wilkinson J, Webb AK, Akhtar M, et al
    Success Rates of Assisted Reproduction for Men With Cystic Fibrosis.
    Pediatr Pulmonol. 2025;60:e27472.
    PubMed     Abstract available


  374. TERLIZZI V, Fevola C, Presti S, Claut L, et al
    Critical Issues in the Management of CRMS/CFSPID Children: A National Real-World Survey.
    Pediatr Pulmonol. 2025;60:e27483.
    PubMed     Abstract available


  375. PAKHATHIRATHIEN P, Maneenil G, Thatrimontrichai A, Dissaneevate S, et al
    Mortality Prediction in Newborns With Persistent Pulmonary Hypertension: A Comparison of Four Illness Severity Scores.
    Pediatr Pulmonol. 2025;60:e27484.
    PubMed     Abstract available


  376. ENOCHS C, Filbrun AG, Hjelm M, Lehrmann J, et al
    Improving implementation and team communication by integrating a cystic fibrosis transition readiness (CF R.I.S.E.) program into electronic health records.
    Pediatr Pulmonol. 2025;60:e27326.
    PubMed     Abstract available


  377. REYNAUD J, Dreyfus L, Coutier L, Butin M, et al
    Efficacy and tolerance of intravenous methylprednisolone pulses in children with severe bronchopulmonary dysplasia requiring respiratory support.
    Pediatr Pulmonol. 2025;60:e27344.
    PubMed     Abstract available


  378. ZUCKERMAN JB, Hinton AC, Lahiri T, Teneback CC, et al
    C-Reactive Protein Changes in Adult and Pediatric People With Cystic Fibrosis During Treatment of Pulmonary Exacerbations.
    Pediatr Pulmonol. 2025;60:e27487.
    PubMed     Abstract available


  379. GUEDES M, Frankel D, Baron SA, Berbis J, et al
    Induced Sputum: A Valuable Tool for Assessing Cellular and Microbiological Characteristics in Cystic Fibrosis Expectorating Teenagers.
    Pediatr Pulmonol. 2025;60:e27488.
    PubMed     Abstract available


  380. KAM CW, McKinzie CJ, Omecene NE, Peters S, et al
    Papilledema in Children With Cystic Fibrosis Receiving Elexacaftor/Tezacaftor/Ivacaftor: A Multicenter Case Series.
    Pediatr Pulmonol. 2025;60:e27455.
    PubMed     Abstract available


  381. OZDEMIR HY, Karcioglu O, Damadoglu E, Kalyoncu AF, et al
    Evaluation of Post-Transfer Clinical Status of Cystic Fibrosis Patients Transferred to Adult Chest Diseases Clinic.
    Pediatr Pulmonol. 2025;60:e27442.
    PubMed     Abstract available


  382. CLARKE E, Taylor J, Watson P, Freeston J, et al
    Prevalence and Distribution of Musculoskeletal Symptoms in Cystic Fibrosis and Impacts on Daily Life.
    Pediatr Pulmonol. 2025;60:e27418.
    PubMed     Abstract available


  383. KARCIOGLU O, Idikut A, Ozturk E, Damadoglu E, et al
    Outcomes of Modulator Therapy Discontinued After Short-Term Use in Adult Cystic Fibrosis.
    Pediatr Pulmonol. 2025;60:e27416.
    PubMed     Abstract available


  384. COYNE S, Condren M
    Case Report: Alpha-Gal Diagnosis in an Adolescent With Cystic Fibrosis.
    Pediatr Pulmonol. 2025;60:e27424.
    PubMed     Abstract available


  385. PASLEY K, Eisner M, Sliemers S, Young R, et al
    Mental Health of Pediatric Patients with Cystic Fibrosis after 18 Months on Elexacaftor-Tezacaftor-Ivacaftor Therapy.
    Pediatr Pulmonol. 2025;60:e27393.
    PubMed     Abstract available


  386. OZTOSUN B, Baskan AK, Arslan H, Korkmaz C, et al
    Respiratory Outcomes of Interrupted Modulator Therapies in Children With Cystic Fibrosis.
    Pediatr Pulmonol. 2025;60:e27390.
    PubMed     Abstract available


  387. PETIT G, Coudert A, Hermann R, Truy E, et al
    Effects of Elexacaftor-Tezacaftor-Ivacaftor on Nasal and Sinus Symptoms in Children With Cystic Fibrosis.
    Pediatr Pulmonol. 2025;60:e27493.
    PubMed     Abstract available


  388. COLBORG A, Smith BM, Green DM, Nasr S, et al
    "It's Like You're Feeding Your Child Twice": Barriers and Facilitators to Human Milk Feeding Children With Cystic Fibrosis.
    Pediatr Pulmonol. 2025;60:e27497.
    PubMed     Abstract available


  389. BOAT T, Hossain MM, Nakamura A, Hjelm M, et al
    Growth, Body Composition, and Strength of Children With Cystic Fibrosis Treated With Elexacaftor/Tezacaftor/Ivacaftor (ETI).
    Pediatr Pulmonol. 2025;60:e27463.
    PubMed     Abstract available


  390. PETTIT RS, Sakon CM, Kinney KE, Brown C, et al
    Predictors of Selective Serotonin Reuptake Inhibitor Treatment Failure in Persons With Cystic Fibrosis.
    Pediatr Pulmonol. 2025;60:e27402.
    PubMed     Abstract available


  391. PAPADAKIS L, Stander T, Mombourquette J, Richards CJ, et al
    Heterogeneity in Reported Side Effects Following Initiation of Elexacaftor-Tezacaftor-Ivacaftor: Experiences at a Quaternary CF Care Center.
    Pediatr Pulmonol. 2025;60:e27382.
    PubMed     Abstract available


  392. LARSEN UL, Agertoft L, Herskind AM, Strom T, et al
    Pulmonary Morbidity in Congenital Diaphragmatic Hernia Survivors Treated at a Non-ECMO Center From 1998 to 2015: A Cross-Sectional Study.
    Pediatr Pulmonol. 2025;60:e27468.
    PubMed     Abstract available


  393. PHALEN RF, Oldham MJ
    Observations on a Tracheobronchial Cast From a Newborn With Trisomy 13.
    Pediatr Pulmonol. 2025;60:e27456.
    PubMed    


    December 2024
  394. DE FIGUEIREDO ARAUJO AG, Bastos de Souza Junior NW, de Oliveira Holanda NS, de Magalhaes FA, et al
    Prediction of Tidal Volume in Newborns Through a Novel Three-Dimensional Model: A Viability Study.
    Pediatr Pulmonol. 2024 Dec 24:e27459. doi: 10.1002/ppul.27459.
    PubMed     Abstract available


  395. YU D, Huang Y, Xu S, Zeng L, et al
    Evaluation of Nucleated Red Blood Cells in Peripheral Blood Increases the Predictive Value of Pediatric Critical Illness Score in Infants With Severe Pneumonia at 28 Days.
    Pediatr Pulmonol. 2024 Dec 24:e27460. doi: 10.1002/ppul.27460.
    PubMed     Abstract available


  396. MADDEN K, Mueller R, Brown C, Valverde KD, et al
    Facilitators and Barriers to Increasing Equity in Cystic Fibrosis Newborn Screening Algorithms.
    Pediatr Pulmonol. 2024 Dec 20:e27449. doi: 10.1002/ppul.27449.
    PubMed     Abstract available


  397. HALE L, Leyens J, Bo B, Engel C, et al
    Implementation of the Oxygen Saturation Index as a Predictor of Outcome in Prenatally Diagnosed CDH Neonates in the First 24 Hours of Life.
    Pediatr Pulmonol. 2024 Dec 17:e27447. doi: 10.1002/ppul.27447.
    PubMed     Abstract available


  398. MARIANI A, Ghezzi E, Pesenti N, Ophorst M, et al
    Nasal High-Flow Therapy Versus Low-Flow Oxygen Therapy Post-Discharge in Infants With Bronchopulmonary Dysplasia: A Retrospective Observational Study.
    Pediatr Pulmonol. 2024 Dec 17:e27450. doi: 10.1002/ppul.27450.
    PubMed     Abstract available


  399. DOZOR AJ, Vincent R
    Assessment of Phrenic Nerve Pacers in a Patient With Congenital Central Hypoventilation Syndrome.
    Pediatr Pulmonol. 2024 Dec 17:e27451. doi: 10.1002/ppul.27451.
    PubMed    


  400. ARMSTRONG S, Harris C, Kazemi M, Lunt A, et al
    Labor Status at Delivery and Lung Function in Extremely Prematurely Born Young Adults.
    Pediatr Pulmonol. 2024 Dec 16:e27440. doi: 10.1002/ppul.27440.
    PubMed     Abstract available


  401. MCINNES E, Lock C, Harman K, Parker J, et al
    Oxygen Prescribing and Compatibility Issues in Infants Requiring Long Term Ventilation.
    Pediatr Pulmonol. 2024 Dec 13:e27408. doi: 10.1002/ppul.27408.
    PubMed    


  402. ZAK SM, Onge IS, Higano NS, Bates AJ, et al
    Clinical Outcomes Through Two Years for Infants With Bronchopulmonary Dysplasia and Tracheomalacia.
    Pediatr Pulmonol. 2024 Dec 5. doi: 10.1002/ppul.27383.
    PubMed     Abstract available


  403. CONTE MS, Ohannesian VA, Costa Junior AS, Jacomelli M, et al
    Tumoral Form of Endobronchial Tuberculosis in an Infant With Central Nervous System Involvement.
    Pediatr Pulmonol. 2024 Dec 2:e27439. doi: 10.1002/ppul.27439.
    PubMed    


  404. REISS A, Lauth W, Wald M
    Premature Infants Show Consistently Good Lung Compliance During Conventional Mechanical Ventilation.
    Pediatr Pulmonol. 2024 Dec 2:e27419. doi: 10.1002/ppul.27419.
    PubMed     Abstract available


  405. KORMELINK LN, Jacobs HR
    Linaclotide Use for the Treatment of Constipation and Gastrointestinal Symptoms in People With Cystic Fibrosis.
    Pediatr Pulmonol. 2024 Dec 2:e27431. doi: 10.1002/ppul.27431.
    PubMed     Abstract available


  406. LOPEZ CARDENES CM, Merino Sanchez-Canete A, Vicente Santamaria S, Gascon Galindo C, et al
    Effects on growth, weight and body composition after CFTR modulators in children with cystic fibrosis.
    Pediatr Pulmonol. 2024;59:3632-3640.
    PubMed     Abstract available


  407. BURDIS N, Milinic T, Bartlett LE, Goss L, et al
    A survey of cystic fibrosis physicians' views on lung transplant referral in the era of elexacaftor/tezacaftor/ivacaftor.
    Pediatr Pulmonol. 2024;59:3641-3649.
    PubMed     Abstract available


  408. YILDIZ CA, Selcuk Balci M, Karabulut S, Baser ZM, et al
    Exploring Turkey's mosaic of novel variants and complex alleles in cystic fibrosis genetics.
    Pediatr Pulmonol. 2024;59:3540-3549.
    PubMed     Abstract available


  409. CHORNEY SR, Beams DR, Nadar A, Afolabi F, et al
    Bronchopulmonary dysplasia and ventilation-associated outcomes after pediatric tracheostomy.
    Pediatr Pulmonol. 2024;59:3530-3539.
    PubMed     Abstract available


  410. LUO L, Li Y, Long Z, Jiang F, et al
    Exploring research trends and hotspots on oxidative stress and bronchopulmonary dysplasia: Insights from bibliometric and visualized study.
    Pediatr Pulmonol. 2024;59:3610-3623.
    PubMed     Abstract available


  411. PASLEY K, Dell ML, May A
    Diagnosis and treatment of ADHD in pediatric patients during the first year of elexacaftor/tezacaftor/ivacaftor.
    Pediatr Pulmonol. 2024;59:3524-3529.
    PubMed     Abstract available


  412. BALCI MS, Gokdemir Y, Eralp EE, Ergenekon AP, et al
    Assessment of patients' baseline cystic fibrosis knowledge levels following translation and adaptation of the CF R.I.S.E translation program into Turkish.
    Pediatr Pulmonol. 2024;59:3483-3490.
    PubMed     Abstract available


  413. MARZOOK N, Dubrovsky AS, Muchantef K, Zielinski D, et al
    Lung ultrasound in children with primary ciliary dyskinesia or cystic fibrosis.
    Pediatr Pulmonol. 2024;59:3391-3399.
    PubMed     Abstract available


  414. FAINARDI V, Cresta F, Sorio C, Melotti P, et al
    Elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis and rare mutations.
    Pediatr Pulmonol. 2024;59:3383-3390.
    PubMed     Abstract available


  415. OMECENE NE, Wilcox N, Cox AL, Ham P, et al
    A review of proton pump inhibitor use in cystic fibrosis and considerations for deprescribing.
    Pediatr Pulmonol. 2024;59:3148-3158.
    PubMed     Abstract available


  416. MCGLYNN JR, Martin A, Aoyama BC, Bamat NA, et al
    Bronchopulmonary dysplasia and diuretic use in an outpatient setting.
    Pediatr Pulmonol. 2024;59:3426-3434.
    PubMed     Abstract available


  417. ROSE NR, Dabbs SG, O'Hagan EC, Guimbellot JS, et al
    Literary evidence of the impact of nonbiological risk factors on CRMS/CFSPID: A scoping review.
    Pediatr Pulmonol. 2024;59:3095-3105.
    PubMed     Abstract available


  418. ZHENG X, Tan Z, Zhu D, Zhao D, et al
    Eclipta prostrata improves alveolar development of bronchopulmonary dysplasia via suppressing the NLRP3 inflammasome in a DLD-dependent manner.
    Pediatr Pulmonol. 2024;59:3371-3382.
    PubMed     Abstract available


  419. HAMIWE T, White DA, Kwenda S, Ismail A, et al
    Detection of the epidemic Pseudomonas aeruginosa AUST-03 (ST242) strain in people with cystic fibrosis in South Africa.
    Pediatr Pulmonol. 2024;59:3340-3348.
    PubMed     Abstract available


  420. NAYIR BUYUKSAHIN H, Yalcin E, Gokirmak I, Ertugrul G, et al
    Evaluation of otorhinolaryngologic, audiologic, and genetic findings in children with cystic fibrosis: A tertiary care experience.
    Pediatr Pulmonol. 2024;59:3298-3305.
    PubMed     Abstract available


  421. SWETLAND DV, Savant AP
    Cystic fibrosis year in review 2023.
    Pediatr Pulmonol. 2024;59:3106-3116.
    PubMed     Abstract available


  422. NIRANJAN SJ, Brown G, Bailey J, Geurs R, et al
    "I eat chocolate milk for dinner because we just have nothing in our fridge": The invisible burden and dire consequences of food insecurity for people with cystic fibrosis in the United States.
    Pediatr Pulmonol. 2024;59:3228-3239.
    PubMed     Abstract available


  423. YILDIZ CA, Selcuk Balci M, Karabulut S, Baser ZM, et al
    Beyond the 10%: Unraveling the genetic diversity in Turkish cystic fibrosis patients not eligible for CFTR modulators.
    Pediatr Pulmonol. 2024;59:3250-3259.
    PubMed     Abstract available


  424. RILEY M, Arigliani M, Davies G, Aurora P, et al
    Looking beyond LCI: Multiple breath washout phase III slope derived indices and their application in chronic respiratory disease in children.
    Pediatr Pulmonol. 2024;59:3085-3094.
    PubMed     Abstract available


  425. SCHECHTER MS, Ostrenga JS, Cromwell EA, Ren CL, et al
    Treatment of small as well as large declines in lung function enhances recovery to baseline in people with CF.
    Pediatr Pulmonol. 2024;59:3212-3220.
    PubMed     Abstract available


  426. ALACHRAF K, Tumin D, Hayes D, Benden C, et al
    Trends in racial and ethnic disparities in pediatric lung transplantation in the United States.
    Pediatr Pulmonol. 2024;59:3204-3211.
    PubMed     Abstract available


  427. PALLA JB
    Disparities and therapeutic advances in cystic fibrosis.
    Pediatr Pulmonol. 2024;59:3812-3818.
    PubMed     Abstract available


    November 2024
  428. HAMADA K, Hirakawa E, Tanabe T, Mine T, et al
    Internal Temperature of Neonatal Endotracheal Tube Predicted by Infrared Thermography: A Neonatal Bench Study.
    Pediatr Pulmonol. 2024 Nov 29:e27425. doi: 10.1002/ppul.27425.
    PubMed     Abstract available


  429. HALBERT-ELLIOTT KM, Sescleifer AM, Mogayzel PJ, Kunisaki SM, et al
    Respiratory Morbidity Among Children Undergoing Surgical Resection for a Congenital Lung Malformation.
    Pediatr Pulmonol. 2024 Nov 29:e27420. doi: 10.1002/ppul.27420.
    PubMed     Abstract available


  430. SHEN L, Wan S, Sun X, Zheng R, et al
    Establishment and evaluation of nomogram for predicting acute respiratory distress syndrome in meconium-stained amniotic fluid neonates.
    Pediatr Pulmonol. 2024 Nov 27. doi: 10.1002/ppul.27345.
    PubMed     Abstract available


  431. ANDERSON MA, Masokano BI, Plummer JW, Willmering MM, et al
    Xe Ventilation and Gas-Exchange MRI Abnormalities in Children with Neuroendocrine Cell Hyperplasia of Infancy (NEHI).
    Pediatr Pulmonol. 2024 Nov 18:e27410. doi: 10.1002/ppul.27410.
    PubMed    


  432. KIMOTO Y, Hirata K, Hirano S, Wada K, et al
    Post-Discharge Growth Among Extremely Preterm Infants With or Without Bronchopulmonary Dysplasia.
    Pediatr Pulmonol. 2024 Nov 8. doi: 10.1002/ppul.27388.
    PubMed     Abstract available


  433. CRUCES P, Alcantar V, Caviedes P, Diaz F, et al
    Critical Asthma in Infancy and Toddlers: How Can We Mechanically Discriminate From Critical Bronchiolitis?
    Pediatr Pulmonol. 2024 Nov 6. doi: 10.1002/ppul.27386.
    PubMed    


  434. LI J, Karabelas P, Gong L, Sheridan CA, et al
    Efficacy of a prototype inspiratory-synchronized small particle versus conventional vibrating mesh nebulizer during pediatric and neonatal mechanical ventilation.
    Pediatr Pulmonol. 2024 Nov 6. doi: 10.1002/ppul.27356.
    PubMed     Abstract available


  435. ZENG Y, Huang Z, Wang Y, Lin B, et al
    Azithromycin for Preventing Bronchopulmonary Dysplasia in Extremely Preterm Infants: A Cohort Study.
    Pediatr Pulmonol. 2024 Nov 6. doi: 10.1002/ppul.27384.
    PubMed     Abstract available


  436. BIRO C, Muirhead C
    Nebulized granulocyte macrophage-colony stimulating factor to stabilize lung function in nontuberculous mycobacteria pulmonary disease in cystic fibrosis.
    Pediatr Pulmonol. 2024;59:3001-3003.
    PubMed    


  437. EMIRALIOGLU N, Cakir B, Sertcelik A, Yalcin E, et al
    Factors associated with pulmonary function decline of patients in the cystic fibrosis registry of Turkey: A retrospective cohort study.
    Pediatr Pulmonol. 2024;59:2956-2966.
    PubMed     Abstract available


  438. MEDBO J, Imberg H, Hansen C, Krantz C, et al
    Telemedicine and home spirometry in cystic fibrosis: A prospective multicenter study.
    Pediatr Pulmonol. 2024;59:2967-2975.
    PubMed     Abstract available


  439. GEORGIOPOULOS AM, DiFiglia S, Seng EK, Portenoy R, et al
    Validation of the Integrated Palliative Care Outcome Scale (IPOS) in adults with cystic fibrosis.
    Pediatr Pulmonol. 2024;59:2857-2866.
    PubMed     Abstract available


  440. VIDAURRETA S, Desantadina V, Galizzi M
    Idiopathic intracranial hypertension in a pediatric patient with cystic fibrosis on ETI generic formulation treatment.
    Pediatr Pulmonol. 2024;59:3009-3011.
    PubMed    


  441. RAIMONDI F
    Tailored surfactant replacement requires accurate evaluation of multiple factors.
    Pediatr Pulmonol. 2024;59:2731.
    PubMed    


  442. LEON C, Martin A, Young LR, Aoyama BC, et al
    Outpatient inhaled corticosteroid use in bronchopulmonary dysplasia.
    Pediatr Pulmonol. 2024;59:2815-2822.
    PubMed     Abstract available


  443. DACCO V, Rosazza C, Mariani A, Rizza C, et al
    Effectiveness and safety of elexacaftor/tezacaftor/ivacaftor treatment in children aged 6-11 years with cystic fibrosis in a real-world setting.
    Pediatr Pulmonol. 2024;59:2792-2799.
    PubMed     Abstract available


  444. DOWLE H, Unger S, Khalid S, Brown C, et al
    Reversible deafness related to long-term daily Azithromycin treatment in a child with cystic fibrosis.
    Pediatr Pulmonol. 2024;59:2990-2992.
    PubMed    


    October 2024
  445. GILLESPIE ML, Jayaram S, Eisner M, Sliemers S, et al
    Edinburgh postnatal depression scale score elevation in caregivers of infants with cystic fibrosis.
    Pediatr Pulmonol. 2024 Oct 29. doi: 10.1002/ppul.27364.
    PubMed     Abstract available


  446. YE D, Yuan T, Jiang M
    Langerhans cell histiocytosis in an infant.
    Pediatr Pulmonol. 2024 Oct 28. doi: 10.1002/ppul.27352.
    PubMed     Abstract available


  447. TESTA I, Muthialu N, Beeman A, Aurora P, et al
    Congenital lobar overinflation, from antenatal diagnosis to long-term follow-up: A single-center experience.
    Pediatr Pulmonol. 2024 Oct 25. doi: 10.1002/ppul.27346.
    PubMed    


  448. GARCIA-ANTON A, Dreyfus L, Portefaix A, Baudin F, et al
    Factors of late respiratory support or oxygen weaning in infants with bronchopulmonary dysplasia.
    Pediatr Pulmonol. 2024 Oct 25. doi: 10.1002/ppul.27367.
    PubMed     Abstract available


  449. RUBINACCI V, Martinelli S, Proto A, Vitelli O, et al
    Necrotizing pneumonia in a preterm baby.
    Pediatr Pulmonol. 2024 Oct 23. doi: 10.1002/ppul.27350.
    PubMed    


  450. LIZ CF, Proenca E
    Oxygen in the newborn pneriod: Could the oxygen reserve index offer a new perspective?
    Pediatr Pulmonol. 2024 Oct 22. doi: 10.1002/ppul.27343.
    PubMed     Abstract available


  451. BRISKI K, Murphy B, Diaz D, Parrott A, et al
    Atypical presentation of primary lung abscess in an infant.
    Pediatr Pulmonol. 2024 Oct 14. doi: 10.1002/ppul.27324.
    PubMed    


  452. NASCIMENTO MS, Khemani RG, Newth CJL
    Challenges in using the ROX index as a predictor of failure in high flow nasal cannula in infants with respiratory failure.
    Pediatr Pulmonol. 2024 Oct 14. doi: 10.1002/ppul.27332.
    PubMed    


  453. STEIN ES, Hevroni A, Zarfati M, Erlichman I, et al
    Comprehensive pulmonary function analysis identifies predominant obstructive phenotype in former premature infants around one year of age.
    Pediatr Pulmonol. 2024 Oct 3. doi: 10.1002/ppul.27287.
    PubMed     Abstract available


  454. TSOI SM, Keller RL
    Prostaglandin E1 in neonatal pulmonary hypertension: Need for randomized trials based on physiology-Response.
    Pediatr Pulmonol. 2024 Oct 3. doi: 10.1002/ppul.27312.
    PubMed    


  455. PIJNENBURG MW
    Long-term respiratory consequences of prematurity.
    Pediatr Pulmonol. 2024 Oct 3. doi: 10.1002/ppul.27304.
    PubMed     Abstract available


  456. PHAM H, Vandeleur M, Mainzer RM, Ranganathan S, et al
    Mental health, sleep, and respiratory health after initiating elexacaftor/tezacaftor/ivacaftor treatment in children with cystic fibrosis.
    Pediatr Pulmonol. 2024;59:2606-2613.
    PubMed     Abstract available


  457. LEE JX, Ryan M, Mukharesh L, Dahlberg SE, et al
    Comparison of home-based spirometry and oscillometry measurements in school-age children with bronchopulmonary dysplasia.
    Pediatr Pulmonol. 2024;59:2589-2596.
    PubMed     Abstract available


  458. HUANG J, Xing G, Kong X
    Lower peripheral blood CD4(+) lymphocyte ratio is associated with severe bronchopulmonary dysplasia.
    Pediatr Pulmonol. 2024;59:2580-2588.
    PubMed     Abstract available


  459. GOOD A, Shannon J, Brinton JT, Hoppe JE, et al
    Implementation and outcomes of a quality improvement project to systematically assess the gross motor skills in school-aged children with cystic fibrosis.
    Pediatr Pulmonol. 2024;59:2597-2605.
    PubMed     Abstract available


  460. NAYIR BUYUKSAHIN H, Emiralioglu N, Yalcin E, Sen V, et al
    Comparison of clinical features of cystic fibrosis patients eligible but not on CFTR modulators to ineligible for CFTR modulators.
    Pediatr Pulmonol. 2024;59:2499-2506.
    PubMed     Abstract available


  461. SHAKKOTTAI A, Kim S, Mitchell RB
    Obstructive sleep apnea in children with cystic fibrosis on highly effective modulator therapy.
    Pediatr Pulmonol. 2024;59:2535-2542.
    PubMed     Abstract available


  462. KUMAR S, Pallin M, Soldatos G
    Codevelopment of a model of care for adults living with cystic fibrosis-related diabetes.
    Pediatr Pulmonol. 2024;59:2472-2481.
    PubMed     Abstract available


  463. REN CL, Nasr SZ, Slaven JE, Joshi A, et al
    Lung T1 MRI assessments in children with mild cystic fibrosis lung disease.
    Pediatr Pulmonol. 2024;59:2464-2471.
    PubMed     Abstract available


    September 2024
  464. KUGELMAN A
    Striving for healthy lungs: Enhancing respiratory outcomes of prematurity.
    Pediatr Pulmonol. 2024 Sep 30. doi: 10.1002/ppul.27309.
    PubMed     Abstract available


  465. KUITUNEN I, Rannankari M, Rasanen K
    Neurally adjusted ventilatory assist (NAVA) in neonatal and pediatric critical care-A scoping review of randomized controlled trials.
    Pediatr Pulmonol. 2024 Sep 27. doi: 10.1002/ppul.27293.
    PubMed     Abstract available


  466. MERINO-MATEO L, Morante R, Lopez M, Jimenez I, et al
    Congenital laryngeal cysts mimicking laryngomalacia.
    Pediatr Pulmonol. 2024 Sep 27. doi: 10.1002/ppul.27298.
    PubMed    


  467. PHAN PH, Tran HMT, Hoang CN, Nguyen TV, et al
    The epidemiology of critical respiratory diseases in ex-premature infants in Vietnam: A prospective single-center study.
    Pediatr Pulmonol. 2024 Sep 25. doi: 10.1002/ppul.27289.
    PubMed     Abstract available


  468. GOUSSARD P, van Wyk L, Gie A, Jacobs C, et al
    Severe airway obstruction due to pulmonary tuberculosis in a premature infant needing decompression of mediastinal lymph nodes.
    Pediatr Pulmonol. 2024 Sep 24. doi: 10.1002/ppul.27282.
    PubMed    


  469. BURATTI CR, Andreolio C, Bruno F, Andrade LB, et al
    Peak inspiratory pressure lacks accuracy to estimate plateau pressure in infants with severe obstructive lower airway disease.
    Pediatr Pulmonol. 2024 Sep 19. doi: 10.1002/ppul.27245.
    PubMed     Abstract available


  470. NGUYEN TA, Matousek J, Kubena A, Resl K, et al
    Ventilator variables predicting extubation readiness in extremely premature infants with prolonged mechanical ventilation: A retrospective observational study.
    Pediatr Pulmonol. 2024 Sep 12. doi: 10.1002/ppul.27265.
    PubMed     Abstract available


  471. MOLNAR Z, van Leuteren RW, Wilinka M, Szczapa T, et al
    Performance and safety of volume guarantee ventilation in neonates using the fabian ventilator, a multicenter study.
    Pediatr Pulmonol. 2024 Sep 12. doi: 10.1002/ppul.27264.
    PubMed     Abstract available


  472. BUSH A
    Interstitial lung disease in infancy and early childhood: Clinical approach.
    Pediatr Pulmonol. 2024 Sep 11. doi: 10.1002/ppul.27254.
    PubMed    


  473. WANG L, Chen L, Liu H
    Recurrent dyspnea caused by congenital lobar emphysema in a premature child.
    Pediatr Pulmonol. 2024 Sep 10. doi: 10.1002/ppul.27252.
    PubMed    


  474. VADYALA M, Tanneru S, Vadije PR, Murki S, et al
    A quality improvement initiative for reducing respiratory care costs in neonates admitted to a tertiary-level NICU in India.
    Pediatr Pulmonol. 2024 Sep 2. doi: 10.1002/ppul.27243.
    PubMed    


  475. SAIKUMAR P, Sadauskas M, Izhar S, Moshiree B, et al
    Constipation and DIOS: Diagnosis, differential diagnosis, and management.
    Pediatr Pulmonol. 2024;59 Suppl 1:S81-S90.
    PubMed     Abstract available


  476. RAMSEY ML, Galante GJ
    Pancreas and pancreatitis: Exocrine pancreatic insufficiency.
    Pediatr Pulmonol. 2024;59 Suppl 1:S44-S52.
    PubMed     Abstract available


  477. JOBANPUTRA AM, Kesavarapu K, Naik S, Ramagopal M, et al
    Overnutrition in persons with cystic fibrosis on modulator therapy and the relationship to obstructive sleep apnea.
    Pediatr Pulmonol. 2024;59 Suppl 1:S27-S35.
    PubMed     Abstract available


  478. GREEN N, Chan C, Ooi CY
    The gastrointestinal microbiome, small bowel bacterial overgrowth, and microbiome modulators in cystic fibrosis.
    Pediatr Pulmonol. 2024;59 Suppl 1:S70-S80.
    PubMed     Abstract available


  479. PALLE SK, Leung DH
    Advanced cystic fibrosis liver disease: Endovascular, endoscopic, radiologic, and surgical considerations.
    Pediatr Pulmonol. 2024;59 Suppl 1:S115-S122.
    PubMed     Abstract available


  480. LYONS ER, Muther E, Sabharwal S
    Nutrition and behavioral health in cystic fibrosis: Eating and body image.
    Pediatr Pulmonol. 2024;59 Suppl 1:S36-S43.
    PubMed     Abstract available


  481. KASPER VL, Assis DN
    Pathophysiology of Cystic Fibrosis Liver Disease.
    Pediatr Pulmonol. 2024;59 Suppl 1:S98-S106.
    PubMed     Abstract available


  482. BASS R, Alvarez JA
    Nutritional status in the era of highly effective CFTR modulators.
    Pediatr Pulmonol. 2024;59 Suppl 1:S6-S16.
    PubMed     Abstract available


  483. SANKARARAMAN S, Freeman AJ
    Early detection of hepatobiliary involvement in cystic fibrosis: Biomarkers, radiologic methods, and genetic influences.
    Pediatr Pulmonol. 2024;59 Suppl 1:S107-S114.
    PubMed     Abstract available


  484. RAZA Z, Islam BN, Hachem CY, Cummings LC, et al
    Evolving data on risk and current screening recommendations for colorectal cancer in cystic fibrosis: Pre- and posttransplant.
    Pediatr Pulmonol. 2024;59 Suppl 1:S91-S97.
    PubMed     Abstract available


  485. GABEL ME, Gaudio RE, Shaikhkhalil AK
    Improving growth in infants with CF.
    Pediatr Pulmonol. 2024;59 Suppl 1:S17-S26.
    PubMed     Abstract available


  486. VELEZ C, Neuringer I, Schwarzenberg SJ
    The foregut in cystic fibrosis.
    Pediatr Pulmonol. 2024;59 Suppl 1:S61-S69.
    PubMed     Abstract available


  487. MILANO RV, Morneault-Gill K, Kamal HY, Barkin JA, et al
    Pancreatitis in cystic fibrosis: Presentation, medical and surgical management, and the impact of modulator therapies.
    Pediatr Pulmonol. 2024;59 Suppl 1:S53-S60.
    PubMed     Abstract available


  488. SATHE M, Stein A
    Remaining barriers to normalcy in cystic fibrosis: Considerations in GI, liver, and nutrition.
    Pediatr Pulmonol. 2024;59 Suppl 1:S5.
    PubMed    


    August 2024
  489. AOYAMA BC, McGrath-Morrow SA, Collaco JM
    Social determinants of health and somatic growth in preterm infants and children with chronic lung disease.
    Pediatr Pulmonol. 2024 Aug 30. doi: 10.1002/ppul.27237.
    PubMed     Abstract available


  490. DERMITZAKI N, Chatzigiannis N, Baltogianni M, Kamperi ME, et al
    Atypical presentation and management of a neonate with alveolar capillary dysplasia: A case report.
    Pediatr Pulmonol. 2024 Aug 28. doi: 10.1002/ppul.27241.
    PubMed    


  491. LUO K, Tang J, Chen H, Zhang X, et al
    Vasodilators for persistent pulmonary hypertension of the newborn: A network meta-analysis.
    Pediatr Pulmonol. 2024 Aug 28. doi: 10.1002/ppul.27234.
    PubMed     Abstract available


  492. MOKHA SA, Lakshminrusimha S
    Prostaglandin E1 in neonatal pulmonary hypertension: Need for randomized trials based on physiology.
    Pediatr Pulmonol. 2024 Aug 28. doi: 10.1002/ppul.27227.
    PubMed    


  493. MADHUSUDAN M, Mohite K, Chandra T, Potti P, et al
    A dual endoscopic approach for a recurrent congenital tracheoesophageal fistula.
    Pediatr Pulmonol. 2024 Aug 27. doi: 10.1002/ppul.27230.
    PubMed    


  494. LIANG GB, Wang L, Huang SQ, Yao ML, et al
    A multicenter epidemiological survey of iNO use in preterm infants in China.
    Pediatr Pulmonol. 2024 Aug 27. doi: 10.1002/ppul.27228.
    PubMed     Abstract available


  495. LI B, Qu SS, Li LX, Zhou N, et al
    Risk factors and clinical outcomes of pulmonary hypertension associated with bronchopulmonary dysplasia in extremely premature infants: A systematic review and meta-analysis.
    Pediatr Pulmonol. 2024 Aug 23. doi: 10.1002/ppul.27220.
    PubMed     Abstract available


  496. MONTAGNA S, Magno D, Ferretti S, Stelluti M, et al
    Combining artificial intelligence and conventional statistics to predict bronchopulmonary dysplasia in very preterm infants using routinely collected clinical variables.
    Pediatr Pulmonol. 2024 Aug 16. doi: 10.1002/ppul.27216.
    PubMed     Abstract available


  497. MICAELLI D, Ghelab Z, Delclaux C, Artu-Dumont C, et al
    Education program for caregivers in congenital central hypoventilation syndrome: Initiation and experience families.
    Pediatr Pulmonol. 2024 Aug 16. doi: 10.1002/ppul.27217.
    PubMed    


  498. DOSSCHE LWJ, van den Aardwegh CS, Kersten CM, van Rosmalen J, et al
    Postnatal chest X-ray in children with asymptomatic congenital lung malformations.
    Pediatr Pulmonol. 2024 Aug 7. doi: 10.1002/ppul.27201.
    PubMed     Abstract available


    July 2024
  499. WYLER F, Manogaran T, Monney N, Salem Y, et al
    Optimized algorithm for speed-of-sound-based infant sulfur hexafluoride multiple-breath washout measurements.
    Pediatr Pulmonol. 2024 Jul 18. doi: 10.1002/ppul.27180.
    PubMed     Abstract available


  500. MENEGOLLA MP, Silveira RC, Gorgen ARH, Gandolfi FE, et al
    Antibiotics and beyond: Unraveling the dynamics of bronchopulmonary dysplasia in very preterm infants.
    Pediatr Pulmonol. 2024 Jul 18. doi: 10.1002/ppul.27182.
    PubMed     Abstract available


  501. CHOUDHARY S, Muise ED, Hammouda S, Goetz D, et al
    New York cystic fibrosis consortium newborn screening quality improvement: Development and implementation of a statewide consensus recommendations for management of infants with CFTR-related metabolic syndrome.
    Pediatr Pulmonol. 2024 Jul 11. doi: 10.1002/ppul.27160.
    PubMed     Abstract available


  502. SANCHEZ-SOLIS M, Forno E, Morales E, Garcia-Marcos L, et al
    Role of body mass index in unbalanced (dysanaptic) lung growth of healthy infants.
    Pediatr Pulmonol. 2024 Jul 5. doi: 10.1002/ppul.27161.
    PubMed     Abstract available


  503. CANELLA R, Feld L, Balmer D, Franklin M, et al
    Using a longitudinal qualitative approach to understand the lived experiences of caregivers of infants with obstructive sleep apnea who require chronic noninvasive respiratory support.
    Pediatr Pulmonol. 2024 Jul 3. doi: 10.1002/ppul.27107.
    PubMed     Abstract available


  504. BROKKEN T, Hutten MC, Ophelders DRMG, van Gorp C, et al
    Optimized lung expansion ventilation modulates ventilation-induced lung injury in preterm lambs.
    Pediatr Pulmonol. 2024 Jul 3. doi: 10.1002/ppul.27153.
    PubMed     Abstract available


  505. NELIN TD, Radack JK, Yang N, Lorch SA, et al
    Associations of PM(2.5) exposure with emergency department visits and readmissions among preterm infants with bronchopulmonary dysplasia.
    Pediatr Pulmonol. 2024 Jul 3. doi: 10.1002/ppul.27164.
    PubMed     Abstract available


  506. MERINO-HERNANDEZ A, Munoz-Cutillas A, Ramos-Navarro C, Bellon-Alonso S, et al
    Long-term lung function follow-up of preterm infants less than 32 weeks of gestational age.
    Pediatr Pulmonol. 2024 Jul 3. doi: 10.1002/ppul.27158.
    PubMed     Abstract available


  507. FICIAL B, Dolce P, Petoello E, Flore AI, et al
    Left atrial strain assessment unveils left ventricular diastolic dysfunction in neonates with transient tachypnea of the newborn: A prospective observational study.
    Pediatr Pulmonol. 2024 Jul 2. doi: 10.1002/ppul.27156.
    PubMed     Abstract available


  508. DE WAAL K
    "Wet lung" of the newborn: Respiratory signs and symptoms caused by cardiac physiology?
    Pediatr Pulmonol. 2024 Jul 2. doi: 10.1002/ppul.27168.
    PubMed    


  509. DE OLIVEIRA TJ, Altoe ID, Arpini LDSB, Liberato FMG, et al
    Clinical and anthropometric evolution of individuals with cystic fibrosis during COVID-19 pandemic: A 24-month cohort study.
    Pediatr Pulmonol. 2024;59:1962-1969.
    PubMed     Abstract available


  510. ELIDOTTIR H, Bjarnadottir SR, Baldursson O, Jonsdottir B, et al
    Cystic fibrosis in Iceland and the high prevalence of the N1303K variant.
    Pediatr Pulmonol. 2024;59:1944-1951.
    PubMed     Abstract available


  511. DE VUYST R, Kam CW, McKinzie CJ, Esther CR, et al
    Medication utilization and lung function changes after initiation of treatment with elexacaftor/tezacaftor/ivacaftor.
    Pediatr Pulmonol. 2024;59:2051-2054.
    PubMed    


  512. SCHUMACHER S, Harklau NM, Osterhaus JK, Wright BA, et al
    Overweight, understudied: The new need for weight loss modalities in CF patients.
    Pediatr Pulmonol. 2024;59:2021-2023.
    PubMed    


  513. MITCHELL E, Albon D
    Clinical effectiveness of elexacaftor/tezacaftor/ivacaftor in a man with A559T and 3120+1G>CFTR variants.
    Pediatr Pulmonol. 2024;59:2009-2011.
    PubMed    


  514. WEINBERGER M, Buettner D
    Commentary addressing concerns raised by Dr. Slovarp and her colleagues.
    Pediatr Pulmonol. 2024;59:1851-1853.
    PubMed    


    June 2024
  515. MCGARRY ME, Sciortino S, Graham S, Bishop T, et al
    Improved detection of cystic fibrosis by the California Newborn Screening Program for all races and ethnicities.
    Pediatr Pulmonol. 2024 Jun 28. doi: 10.1002/ppul.27155.
    PubMed     Abstract available


  516. MARCZAK H, Peradzynska J, Paplinska-Goryca M, Misiukiewicz-Stepien P, et al
    Serum biomarkers in neuroendocrine cell hyperplasia of infancy.
    Pediatr Pulmonol. 2024 Jun 27. doi: 10.1002/ppul.27148.
    PubMed     Abstract available


  517. WRIGHT M, Knowles RL, Cortina-Borja M, Javadpour S, et al
    Airway management in infants with Robin sequence in the United Kingdom and Ireland: A prospective population-based study.
    Pediatr Pulmonol. 2024 Jun 21. doi: 10.1002/ppul.27140.
    PubMed     Abstract available


  518. WACHSMUTH L, Bieli C, Grehten P, Moehrlen T, et al
    Sleep-disordered breathing on respiratory polygraphy in neonates with spina bifida.
    Pediatr Pulmonol. 2024 Jun 18. doi: 10.1002/ppul.27137.
    PubMed     Abstract available


  519. JI F, Gu X, Bao Y, Zhang Q, et al
    Association between Ureaplasma colonization and bronchopulmonary dysplasia defined by different criteria in very low birth weight infants: A retrospective cohort study.
    Pediatr Pulmonol. 2024 Jun 14. doi: 10.1002/ppul.27121.
    PubMed     Abstract available


  520. GURBANI N, Ehsan Z, Boh M, Schuler CL, et al
    Comparison of high flow nasal cannula therapy to nasal oxygen as a treatment for obstructive sleep apnea in infants.
    Pediatr Pulmonol. 2024 Jun 5. doi: 10.1002/ppul.27109.
    PubMed     Abstract available


  521. MIRAFTABI P, Kirjavainen T, Lohi J, Martelius L, et al
    The original histopathologic description of neuroendocrine cell hyperplasia of infancy is not applicable to every patient with the disease.
    Pediatr Pulmonol. 2024 Jun 5. doi: 10.1002/ppul.27118.
    PubMed    


  522. STEWART KL, Szczesniak R, Liou TG
    Predicting weight gain in patients with cystic fibrosis on triple combination modulator.
    Pediatr Pulmonol. 2024;59:1724-1730.
    PubMed     Abstract available


  523. GUO J, King I, Hill A
    International disparities in diagnosis and treatment access for cystic fibrosis.
    Pediatr Pulmonol. 2024;59:1622-1630.
    PubMed     Abstract available


  524. WYATT ML, Sokolow AG, Brown RF, Kaslow JA, et al
    Prevalence, stability, and clinical significance of an isolated low FEV(1) spirometry pattern in children.
    Pediatr Pulmonol. 2024;59:1747-1756.
    PubMed     Abstract available


  525. BATHGATE JR, Pike K, Newkirk M, Rigassio Radler DL, et al
    Development of a bronchopulmonary dysplasia nutrition focused physical examination tool: A modified Delphi study.
    Pediatr Pulmonol. 2024;59:1695-1707.
    PubMed     Abstract available


  526. CUNEO A, Smith-Thomas T, Marsac M
    Opportunities for trauma-informed medical care in cystic fibrosis.
    Pediatr Pulmonol. 2024;59:1814-1816.
    PubMed    


  527. MCKINZIE CJ, Kam CW, Jones MC, Gifford LB, et al
    Elevated creatine phosphokinase and rhabdomyolysis associated with elexacaftor/tezacaftor/ivacaftor use in cystic fibrosis.
    Pediatr Pulmonol. 2024;59:1795-1797.
    PubMed    


  528. KUMAR M, Aaron R, Varkki SD, Danda S, et al
    A rare variant c.1802T>C (p. Ile601Thr) associated with severe phenotype among people with cystic fibrosis from south India, and potential genetic admixture in Reunion, France.
    Pediatr Pulmonol. 2024;59:1820-1825.
    PubMed    


  529. SHERWOOD SJ, Tak C, Bhakta ZN, Packer K, et al
    A comparison of aminoglycoside antibiotic serum concentrations collected by peripheral veins and peripherally inserted central catheters in adults with cystic fibrosis.
    Pediatr Pulmonol. 2024;59:1740-1746.
    PubMed     Abstract available


  530. BERLIN KEK, Lagatta J, Dawson S, Malnory M, et al
    Inpatient education reduces length of outpatient oxygen therapy in bronchopulmonary dysplasia: A quality improvement project.
    Pediatr Pulmonol. 2024;59:1677-1685.
    PubMed     Abstract available


  531. CARROLL BJ, Ostrenga JS, Fink AK, Antos NJ, et al
    Clinical outcomes at 9-10 years of age in children born with cystic fibrosis transmembrane conductance regulator related metabolic syndrome.
    Pediatr Pulmonol. 2024;59:1606-1613.
    PubMed     Abstract available


  532. LANDESS L, Prieur MG, Brown AR, Dellon EP, et al
    Exploring perceptions of and decision-making about CFTR modulators.
    Pediatr Pulmonol. 2024;59:1614-1621.
    PubMed     Abstract available


  533. AGARWAL A, McKinney RL, Baker CD, Nelin LD, et al
    Adapting to changing ventilator access: Impact on management of severe bronchopulmonary dysplasia in children.
    Pediatr Pulmonol. 2024;59:1803-1806.
    PubMed    


  534. O'DONNELL JEM, Hastings LA, Briody JN, Chan CL, et al
    SHIFTing goals in cystic fibrosis-managing extrapulmonary disease in the era of CFTR modulator therapy; Proceedings of the International Shaping Initiatives and Future Trends (SHIFT) Symposium.
    Pediatr Pulmonol. 2024;59:1661-1676.
    PubMed     Abstract available


    May 2024
  535. GRIESE M, Seidl E
    Persistent tachypnea of infancy, neuroendocrine cell hyperplasia of infancy, and pulmonary interstitial glycogenosis: "A3-Specific conditions of undefined etiology".
    Pediatr Pulmonol. 2024 May 31. doi: 10.1002/ppul.27102.
    PubMed    


  536. SCHMIDT HP, Paskaradevan J
    Anomalous systemic venous return: An extremely rare cause of hypoxemia in a neonate.
    Pediatr Pulmonol. 2024 May 27. doi: 10.1002/ppul.27074.
    PubMed    


  537. DOSSCHE L, Kersten C, van Rosmalen J, Wijnen R, et al
    Lower respiratory tract infections in children with congenital lung abnormalities.
    Pediatr Pulmonol. 2024 May 21. doi: 10.1002/ppul.27067.
    PubMed     Abstract available


  538. CHEN C, Jin Y, Jin H, Chen S, et al
    Adipose mesenchymal stem cells-derived exosomes attenuated hyperoxia-induced lung injury in neonatal rats via inhibiting the NF-kappaB signaling pathway.
    Pediatr Pulmonol. 2024 May 21. doi: 10.1002/ppul.27057.
    PubMed     Abstract available


  539. NOBILE S, Catalano P, Perri A, Lio A, et al
    Lung agenesis in a preterm infant: Lung function test findings in the first 2 years of life.
    Pediatr Pulmonol. 2024 May 15. doi: 10.1002/ppul.27042.
    PubMed    


  540. MANIACI J, Kearney MD, DeMauro SB, Panitch H, et al
    Lived experiences of caregivers with infants treated at home with continuous invasive or noninvasive ventilation.
    Pediatr Pulmonol. 2024 May 15. doi: 10.1002/ppul.27063.
    PubMed     Abstract available


  541. RAO T, Zhou Y, Chen C, Chen J, et al
    Recent progress in neonatal hyperoxic lung injury.
    Pediatr Pulmonol. 2024 May 14. doi: 10.1002/ppul.27062.
    PubMed     Abstract available


  542. SANCHEZ-FERRER F, Nso-Roca AP
    Unusually severe neonatal presentation of mediastinal bronchogenic cyst.
    Pediatr Pulmonol. 2024 May 14. doi: 10.1002/ppul.27048.
    PubMed     Abstract available


  543. DE MEDEIROS CAVALCANTE MENEGHE, Aragon DC, Calixto C, Ferreira CHF, et al
    Personalized lung care: Bronchopulmonary dysplasia risk prediction tool tailored for neonates born in resource-limited settings.
    Pediatr Pulmonol. 2024 May 7. doi: 10.1002/ppul.27049.
    PubMed     Abstract available


  544. BULLON-GONZALEZ I, Cabeza-Arce N, Andres-Porras P, Ferrer-Ortiz I, et al
    Lessons from Covid: Effect of community mask use on infant hospitalizations for respiratory infections.
    Pediatr Pulmonol. 2024 May 7. doi: 10.1002/ppul.27043.
    PubMed    


  545. WU YH, Hsiao CH, Chen YL, Tsai LY, et al
    Rare type of tracheal agenesis: Unexpected presentation and immediate consideration of emergent esophageal intubation in neonatal resuscitation program. Case reports and review of the literature.
    Pediatr Pulmonol. 2024 May 2. doi: 10.1002/ppul.26990.
    PubMed     Abstract available


  546. KAY DM, Sadeghi H, Kier C, Berdella M, et al
    Genetic counseling access and service delivery in New York State is variable for parents of infants with complex CFTR genotypes conferring uncertain phenotypes.
    Pediatr Pulmonol. 2024 May 2. doi: 10.1002/ppul.27023.
    PubMed     Abstract available


  547. JIMENEZ-NOGUEIRA E, Bueno-Rebollo C, Garcia-Jerez B, Callejon-Fernandez E, et al
    Impact of breastfeeding on ICU admissions and need for mechanical ventilation in infants younger than 6 months with RSV+ bronchiolitis. An observational study.
    Pediatr Pulmonol. 2024 May 2. doi: 10.1002/ppul.27036.
    PubMed     Abstract available


  548. URQUHART DS, Dowle H, Moffat K, Forster J, et al
    Lung clearance index (LCI(2.5)) changes after initiation of Elexacaftor/Tezacaftor/Ivacaftor in children with cystic fibrosis aged between 6 and 11 years: The "real-world" differs from trial data.
    Pediatr Pulmonol. 2024;59:1449-1453.
    PubMed     Abstract available


  549. YOUSIF D, Cerini C, Ward S, Iyer N, et al
    Retrospective study of serial polysomnograms of bronchopulmonary dysplasia patients with oxygen dependence.
    Pediatr Pulmonol. 2024;59:1418-1427.
    PubMed     Abstract available


  550. BENDOUKHA I, Boucherit-Otmani Z, Baba Ahmed-Kazi Tani ZZ, Seghir A, et al
    Initial characteristics of cystic fibrosis in Algeria: Description of 34 pediatric cases.
    Pediatr Pulmonol. 2024;59:1454-1461.
    PubMed     Abstract available


  551. HARRIGAN M, Jessup M, Bennett K, Mulrennan S, et al
    Me, myself, and I: A systematic review of cystic fibrosis and self-concept.
    Pediatr Pulmonol. 2024;59:1175-1195.
    PubMed     Abstract available


  552. GAMBAZZA S, Mariani A, Guarise R, Ferrari B, et al
    Short-term effects of positive expiratory pressure mask on ventilation inhomogeneity in children with cystic fibrosis: A randomized, sham-controlled crossover study.
    Pediatr Pulmonol. 2024;59:1354-1363.
    PubMed     Abstract available


  553. WRIGHT BA, De Andrade LM, Dumitrescu AV, Larson SA, et al
    A new vision: Integration of ophthalmology services into an interdisciplinary pediatric cystic fibrosis clinic model.
    Pediatr Pulmonol. 2024;59:1502-1504.
    PubMed    


  554. ATTEIH SE, Armbruster CR, Hilliam Y, Rapsinski GJ, et al
    Effects of highly effective modulator therapy on the dynamics of the respiratory mucosal environment and inflammatory response in cystic fibrosis.
    Pediatr Pulmonol. 2024;59:1266-1273.
    PubMed     Abstract available


  555. POULSEN M, Holland AE, Button B, Jones AW, et al
    Preferences and perspectives regarding telehealth exercise interventions for adults with cystic fibrosis: A qualitative study.
    Pediatr Pulmonol. 2024;59:1217-1226.
    PubMed     Abstract available


    April 2024
  556. ARADHYA AS, Ghalige SS, Madarkar B, Pruthvishree HV, et al
    Comparison of porcine versus bovine surfactant in preterm respiratory distress syndrome: Evidence from real-world data. A multicentre collaboration from Karnataka.
    Pediatr Pulmonol. 2024 Apr 25. doi: 10.1002/ppul.27032.
    PubMed     Abstract available


  557. TSOU PY, Tapia IE
    Tracheostomy and inpatient outcomes among children with congenital central hypoventilation syndrome: A kids' inpatient database study.
    Pediatr Pulmonol. 2024 Apr 17. doi: 10.1002/ppul.27015.
    PubMed     Abstract available


  558. LOHMANN P, Hagan JL, Fernandes CJ
    A breath of fresh air: Does spontaneous breathing and early repair in neonates with very mild congenital diaphragmatic hernia lead to earlier discharge?
    Pediatr Pulmonol. 2024 Apr 17. doi: 10.1002/ppul.27003.
    PubMed    


  559. LEFEVERE J, van Delft B, Decaluwe W, Derriks F, et al
    Neurally adjusted ventilatory assist in preterm infants: A systematic review and meta-analysis.
    Pediatr Pulmonol. 2024 Apr 3. doi: 10.1002/ppul.27001.
    PubMed     Abstract available


  560. DUDOIGNON B, Khirani S, Vedrenne-Cloquet M, Amaddeo A, et al
    Work of breathing: A tool for the respiratory management of severe bronchopulmonary dysplasia.
    Pediatr Pulmonol. 2024;59:1128-1132.
    PubMed    


  561. TAMER G, Arets HGM, van der Ent CK, van Santen HM, et al
    BMI increase during early childhood in boys with cystic fibrosis and early adrenarche.
    Pediatr Pulmonol. 2024;59:991-996.
    PubMed     Abstract available


  562. VAZIRI S, McGarry ME, Huang CY, Cuneo AA, et al
    Time to be blunt: Substance use in cystic fibrosis.
    Pediatr Pulmonol. 2024;59:1015-1027.
    PubMed     Abstract available


  563. WELSNER M, Gruber W, Blosch C, Olivier M, et al
    Impact of habitual physical activity and exercise capacity on quality of life in adolescents and adults with cystic fibrosis.
    Pediatr Pulmonol. 2024;59:949-963.
    PubMed     Abstract available


  564. ZAFAR A, Hall M
    Types of home respiratory support in children with bronchopulmonary dysplasia and factors determining its duration: A scoping review.
    Pediatr Pulmonol. 2024;59:834-844.
    PubMed     Abstract available


  565. POWER HA, Shivak SM, Kim J, Wright KD, et al
    A systematic review of attention-deficit/hyperactivity disorder in people living with cystic fibrosis.
    Pediatr Pulmonol. 2024;59:825-833.
    PubMed     Abstract available


  566. ZWITSERLOOT AM, Verhoog FA, van den Berge M, Gappa M, et al
    Comparison of particles in exhaled air and multiple breath washout for assessment of small airway function in children with cystic fibrosis.
    Pediatr Pulmonol. 2024;59:915-922.
    PubMed     Abstract available


  567. PATEL N, Ansar M, Pham A, Thomsen K, et al
    Gilbert's syndrome leads to elevated bilirubin after initiation of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis.
    Pediatr Pulmonol. 2024;59:863-866.
    PubMed     Abstract available


  568. MAYNARD R, Armstrong M, O'Grady K, Moore B, et al
    Predischarge death or lung transplantation in tracheostomy and ventilator dependent grade 3 bronchopulmonary dysplasia.
    Pediatr Pulmonol. 2024;59:867-873.
    PubMed     Abstract available


  569. SUBRAMANIAN P, Singhal M, Sharma A
    Unique segmental branching of right pulmonary artery in association with patent ductus arteriosus and anomalous carotid origin of left vertebral artery.
    Pediatr Pulmonol. 2024;59:1092-1094.
    PubMed    


    March 2024
  570. LEON-ASTUDILLO C, Dy FJ, McCown MY, Perez IA, et al
    ATS core curriculum 2023. Pediatric pulmonary medicine: Respiratory disorders in infants.
    Pediatr Pulmonol. 2024 Mar 28. doi: 10.1002/ppul.26961.
    PubMed     Abstract available


  571. MIZOGAMI M, Hasegawa H, Yamada Y, Wasa M, et al
    Examination of changes in the breathing intolerance index to determine the respiratory support needs of very low birth weight infants.
    Pediatr Pulmonol. 2024 Mar 19. doi: 10.1002/ppul.26969.
    PubMed     Abstract available


  572. DE QUEIROZ ANDRADE E, Sena CRDS, de Gouveia Belinelo P, Robinson PD, et al
    In utero smoking exposure induces changes to lung clearance index and modifies risk of wheeze in infants.
    Pediatr Pulmonol. 2024 Mar 19. doi: 10.1002/ppul.26975.
    PubMed     Abstract available


  573. TARRELL A, Grinsell M, Lewis KW, Yoder BA, et al
    Bronchopulmonary dysplasia severity and bone status in preterm infants.
    Pediatr Pulmonol. 2024 Mar 19. doi: 10.1002/ppul.26967.
    PubMed    


  574. NOUR BA, El-Rahman AMA, Hameed SAEAE, Mohsen N, et al
    Lung and diaphragm ultrasound as predictors of successful weaning from nasal continuous positive airway pressure in preterm infants.
    Pediatr Pulmonol. 2024 Mar 19. doi: 10.1002/ppul.26933.
    PubMed     Abstract available


  575. PERRI A, Prontera G, Fattore S, Sbordone A, et al
    Tracheal bronchus related symptoms in a premature neonate: The role of lung ultrasound in the management of this condition.
    Pediatr Pulmonol. 2024 Mar 5. doi: 10.1002/ppul.26944.
    PubMed    


  576. DANI C, Miselli F, Zini T, Scarponi D, et al
    Measurement of lung oxygenation by near-infrared spectroscopy in preterm infants with bronchopulmonary dysplasia.
    Pediatr Pulmonol. 2024 Mar 5. doi: 10.1002/ppul.26955.
    PubMed     Abstract available


  577. KIER C, Kay DM, Langfelder-Schwind E, Goetz DM, et al
    Variability in evaluation and follow-up of newborns with CRMS/CFSPID in New York State.
    Pediatr Pulmonol. 2024 Mar 1. doi: 10.1002/ppul.26928.
    PubMed    


    January 2024
  578. DANI C, Napolitano M, Barone C, Manna A, et al
    Nasal intermittent positive pressure ventilation during less invasive surfactant administration in preterm infants: An open-label randomized controlled study.
    Pediatr Pulmonol. 2024 Jan 22. doi: 10.1002/ppul.26879.
    PubMed     Abstract available


    October 2023
  579. GUPTA R, Bandyopadhyay T, Yadav B, Guleria M, et al
    Sonographic assessment of diaphragmatic thickness and excursion to predict CPAP failure in neonates below 34 weeks of gestation: A prospective cohort study.
    Pediatr Pulmonol. 2023;58:2889-2898.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Neonatology is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum